JP Legal Announces Major Milestones and Continued Expansion in the GCC Region

EQS Newswire / 02/09/2024 / 10:19 UTC+8 Riyadh, Saudi Arabia - September 02, 2024 - (SeaPRwire) - JP Legal, a leading law firm operating across the Gulf Cooperation Council (GCC), has established itself as a premier legal partner for both regional and international clients. With a deep understanding of the legal and cultural nuances of the GCC, particularly Saudi Arabia, JP Legal is at the forefront of advising multinationals companies on complex transactions, and on expanding their market presence, and executing high-value transactions. Acting for Major Clients Across the Region JP Legal advised recently BLOMINVEST Saudi Perfume Fund on the acquisition of an 18% minority stake in Dkhoon AlEmiratia, a leading Saudi perfume company. Valued at over SAR 250 million, this transaction not only highlights the firm's expertise in managing complex mergers and acquisitions (M&A) but also underscores the growing importance of investing in Saudi companies as part of the Vision 2030 initiative. The transaction was handled by JP Legal's multidisciplinary team, led by Riyadh based Corporate/M&A Partner, Anas El Jisr. JP Legal has earned the trust of some of the region's most prominent corporations and brands, providing legal counsel to giants such as Al Rajhi Investment, Othaim Group, Elie Saab, and Anghami. The firm's work with Al Rajhi Investment and Othaim Group showcases its ability to handle large-scale, high-stakes transactions and legal matters that are critical to the growth and success of these leading entities in the Saudi market. In addition to advising these major clients, JP Legal has been instrumental in guiding Anghami, the leading music streaming service in the Middle East, on its business operations in Saudi Arabia and it's on securing proper Saudi approvals in parallel with its NASDAQ listing and merger with US Vistas Inc. Furthermore, JP Legal has supported Apotex Inc., a leading pharmaceutical company, in setting up their regional headquarters in Saudi Arabia and the global luxury fashion brands Elie Saab, and Natuzzi's exclusive distributor Furniture Solutions in establishing and expanding its retail footprint in the heart of Riyadh, further solidifying its presence in the Saudi market. Global Expertise with a Diverse Legal Team JP Legal has diverse and highly qualified legal team, which includes lawyers admitted to practice in multiple jurisdictions. The firm recruits top legal talent from around the world, including UK-qualified solicitors, and attorneys licensed in Saudi Arabia, the UAE, Lebanon, Pakistan, Canada, France, and beyond. This extensive legal expertise allows JP Legal to provide exceptional service and comprehensive legal solutions tailored to the specific needs of its clients, whether they are navigating local regulations or engaging in complex cross-border transactions. Embracing AI to Revolutionize Legal Services In an industry traditionally dominated by manual processes, JP Legal has embraced artificial intelligence (AI) to enhance its market presence and service delivery in the GCC region. The firm has integrated AI across several key areas of its practice, including legal research, due diligence, and document management. By leveraging AI, JP Legal has significantly improved the efficiency and accuracy of its legal work, allowing its attorneys to access comprehensive legal information rapidly and conduct thorough due diligence in a fraction of the time it would take using traditional methods. Despite the significant role of AI in its operations, JP Legal emphasizes that technology is a tool to augment, not replace, human expertise. The firm's lawyers work in tandem with AI systems, using their judgment and experience to interpret and apply AI-generated insights. This symbiotic relationship between humans and AI allows JP Legal to offer a unique blend of technological efficiency and personalized service, ensuring that clients receive faster, more accurate legal work without sacrificing the nuanced understanding and strategic thinking that only human lawyers can provide. Leadership and Vision for the Future Under the visionary leadership of Managing Partner Anas El Jisr, JP Legal has grown exponentially, both in terms of its team and its market presence. The firm has recruited senior legal professionals from major regional and international firms, further strengthening its capabilities. This growth has positioned JP Legal as a formidable competitor to both regional and global law firms, particularly in cross-border transactions where JP Legal frequently represents major local Saudi conglomerates and multinational corporations. JP Legal's commitment to innovation and excellence is reflected in its ability to adapt to the rapidly evolving legal landscape. The firm continuously seeks to improve its methodologies and technologies, ensuring that it remains at the cutting edge of legal practice in the GCC region. JP Legal's success is built on a foundation of deep regional expertise, a client-centric approach, and a forward-thinking strategy that embraces the transformative potential of AI. By providing tailored legal solutions that meet the sophisticated needs of both emerging businesses and established corporations, JP Legal has cemented its reputation as a leading law firm in the GCC region. As the firm continues to grow and innovate, it remains dedicated to helping its clients navigate the complexities of the legal landscape, achieve their business objectives, and capitalize on the opportunities presented by Saudi Arabia's Vision 2030 initiative. About JP Legal JP Legal is a consultancy firm with a strong regional presence in the Kingdom of Saudi Arabia and the United Arab Emirates. Specializing in corporate and commercial laws and transactions, the firm serves a diverse clientele that includes small boutique firms and large multinational corporations. Contact information Company: JP Legal Contact: Hadi Sabra Email: hadi.s@j-plegal.com Website: https://www.j-plegal.com/ 02/09/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

High Growth, High Dividends, High Potential: China Hongqiao (01378.HK) Achieves Leapfrog Development in H1 2024

EQS Newswire / 02/09/2024 / 10:15 UTC+8 Recently, China Hongqiao (01378.HK), a global market leader in the aluminum industry, released a remarkable interim results announcement, attracting significant market attention. China Hongqiao has demonstrated accelerated development in the first half of 2024, various performance indicators of the company showed a substantial year-on-year growth, with figures increased far exceeding those announced during the positive profit alert released by the Group in June. In particular, the company’s profit has surged by over three times, setting a historic peak. Remarkable Growth in Financial Performance and Dividends In the first half of the year, China Hongqiao achieved a revenue of RMB 73.592 billion, representing a 12.0% year-on-year increase. The net profit attributable to equity holders was RMB 9.155 billion, representing a significant increase of 272.66% year-on-year. The net profit excluding extraordinary profit and loss was RMB 10.77 billion, representing a substantial year-on-year increase of 352.68%. Basic earnings per share increased by approximately 273.0% year-on-year to RMB 0.966. In addition to the growth in revenue and net profit, China Hongqiao also saw a significant increase in gross profit and gross profit margin. In the first half of the year, the company's gross profit increased by approximately 202.1% year-on-year to RMB 17.802 billion, while the overall gross margin was about 24.2%, showing a significant increase of 15.2 percentage points compared to 9.0% in the same period last year. China Hongqiao’s rapid performance growth is driven by both increased product volume and prices, alongside a reduction in cost of key raw materials. "The average selling prices of the Group's aluminum alloy products and alumina products increased compared to the same period in 2023, at the same time, the increase in sales volume and the reduction in purchase prices of key raw materials such as coal and anode carbon blocks were also the favorable factors, thus the Group's gross profit saw a significant increase compared to the same period in 2023," said Mr. Zhang Bo, Chairman of the Board of China Hongqiao. The rising demand in the aluminum industry also contributed to the improvement in China Hongqiao's performance. As inflation continues to moderate globally, and major central banks contemplating potential rate cuts, better than expected improvements in economic performances for major countries are observed, with key growth indicators exhibiting an upward trend. In the context of a slow economic recovery, there are renewed expectations for increased demand for metals like copper and aluminum, driven by industries such as photovoltaics and electric vehicles. Additionally, the supply capacity for certain types of ore and smelting process is experiencing a periodic weaknesses, leading to a significant overall increase in the prices of non-ferrous metals, including aluminum, in the second quarter of 2024. According to Guosheng Securities, with the completion of China Hongqiao’s relocation on electrolytic aluminum production to Yunnan Province, the production cost of electrolytic aluminum is expected to reduce further. Meanwhile, aluminum prices are expected to remain high due to rigid domestic supply and the post-interest rate hike cycle. The increase in both prices and sales volume is foreseen under the expectation of the US Federal Reserve’s rate cuts and increased use of aluminium in green energy applications. All these positive factors further enhance the company’s performance elasticity. As profits surges, China Hongqiao also highly focused on delivering strong returns to its shareholders, China Hongqiao also places great emphasis on shareholders’ returns and continues to increase its dividend payout ratio. In the first half of the year, the company declared a dividend of HKD 0.59 per share, showing a year-on-year increase of 73.5%, with a dividend yield of approximately 5.72% and a payout ratio of 56%. The company's average dividend payout ratio has consistently ranked among the top tier within the industry, providing a stronger secured margin to its shareholders since it became a listed company in HKEX from 2011. Moreover, China Hongqiao currently has a strong cash flow. As at June 30, 2024, the company held approximately RMB 37.502 billion in cash and cash equivalents, which also helps ensuring the stability and flexibility of its business operations. Integrated Industry Chain Highlights Advantages with Strong Momentum for Performance Growth The significant growth in China Hongqiao's performance is not only a result of the overall improvement in industry demand but also the outcome of the company's commitment to building an integrated industry chain and continuously enhancing its internal innovation capabilities. Chairman of the Board Mr. Zhang Bo highlighted that the company is currently at a critical stage of transforming and upgrading from traditional industries, developing and expanding emerging industries, and exploring future industry layouts. During this period, China Hongqiao continued to cement its presence in the aluminum industry, further strengthening its full industry chain from bauxite, alumina, primary aluminum, aluminum deep processing, to recycled aluminum. The company has continuously deepened the conversion of new and old growth drivers, leveraging new technologies to empower sustainable development, and consistently increasing the role of “Green” in business growth. As China Hongqiao continues to enhance its industrial chain, it is also proactively expanding into international markets. The company is currently cooperating with countries and regions such as India, Europe, Malaysia, North America, and other Southeast Asian regions. The key materials for electrolytic aluminum production are alumina, electricity, and prebaked anodes. China Hongqiao has made arrangements for bauxite resources in Guinea and Indonesia while expanding its sources of raw materials from Australian bauxite, this ensures the diversification of raw material supply to reduce exposures to raw material risks. As at March 2024, China Hongqiao's project in Guinea has maintained an annualized production capacity of approximately 50 million tonnes of bauxite, with a total alumina production capacity of 19.5 million tonnes per year (including 17.5 million tonnes per year of domestic alumina production capacity and 2 million tonnes per year of Indonesian alumina production capacity). The company has become fully self-sufficient in alumina, highlighting its advantages through all-round integration. Currently, China Hongqiao's total electrolytic aluminum production capacity has reached 6.46 million tonnes per year, and the company plans to relocate a total of 3.96 million tonbes per year of capacity to Yunnan, which is expected to further reduce the overall electricity costs of the company's total production capacity. While China Hongqiao previously relied primarily on coal-fired power for its energy consumption, in response to national policies and with the support of the Yunnan government, the company has relocated part of its capacity to Yunnan to fully utilize the local hydropower advantages. Additionally, the company is vigorously investing in clean energy projects such as photovoltaics in both Yunnan and Shandong, increasing the proportion of clean energy. China Hongqiao continues to build itself as a global market leader in the integrated aluminum industry chain, with industry chain advantages bringing cost advantages to the company. At the same time, the company's capacity relocation actively adapts to the on-going low-carbon development trends. Along with the company's internal initiatives to enhance both the quality and the efficiency, and external efforts to expand international markets, China Hongqiao is further unleashing its strong development momentum and continuously unlocking its potential for significant performance growth. 02/09/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Huitongda Network (9878.HK): Further Upgrading in Supply Chain Capacity Opens A New Chapter of Growth

EQS Newswire / 30/08/2024 / 18:21 UTC+8 Huitongda Network Co., Ltd. (9878. HK) released its 2024 interim report on August 28th. Data shows that the Group achieved a revenue of 32.86 billion yuan in the first half of the year, a net profit attributable to the parent company of 130 million yuan, and a stable positive inflow of operating cash flow of nearly 249 million yuan. Amidst the slow global economic recovery and domestic macroeconomic fluctuations, the Group has adjusted its development strategy to enhance the quality and depth of the business, manifesting its robust and high-value development strategy. It is not difficult to find far-reaching growth logic and strategic value behind the in-depth analysis of financial report data: the Group is gradually unlocking new growth potential and building a more solid foundation for sustainable development in the future by relying on its profound accumulation and forward-looking layout in continuous innovation of industrial models and deep market cultivation. Building An Independent & Controllable Supply Chain to Lead the New Trend of Industrial Upgrading In the first half of the year, Huitongda Network made "ensuring stable growth with high quality to innovate for a better future" its core principle on work for the year, and achieved significant results in vigorously promoting the transformation and upgrading of its business. Its supply chain capability has steadily increased, driving the continuous improvement of the company's operating quality with the gross profit margin up by 0.5 percentage points year-on-year, demonstrating the effective enhancement of the company's profitability Specifically, the Group deepened cooperation with top brands in various industries, including Gree, Midea, and AUX in the home appliance industry, new with Siemens and OUTES; Apple in the consumer electronics industry, followed by the upgrading of 1464 O2O stores in towns and villages; BYD, NETA, and SAIC Group in the vehicles and auto parts merchandise industry; VOGELY, Newoasis Wood Floor, etc. in the homebuilding and renovation materials industry; Unilever and others in the cleaning chemicals industry. This not only solidified the company's position in traditional advantageous areas, but also further enriched its product line and service scope. Compared with other competitors in the market, the Group focuses on six major categories: consumer electronics, household appliances, agricultural means of production, vehicles and auto parts merchandise, homebuilding and renovation materials, and liquor and beverages and is one of the few top service providers that covers large durable goods with a wide range of categories. At present, the Group has established cooperation with over a thousand high-quality brand owners and manufacturers. With the further enhancement of supply chain capabilities, the combination of collective purchasing and marketing models with abundant downstream resources is expected to further strengthen its upstream bargaining power and consolidate procurement costs advantages. Moreover, the Group expanded its cooperation with resource-based enterprises, such as Ningxia Lanfeng Fine Chemical Co., Ltd. in the agriculture means of production industry; Hainan Agricultural Reclamation Investment Holding Group Co., Ltd. and Xiayi Jinzhan Wood Industry Co., Ltd. in the homebuilding and renovation materials industry. Meanwhile, the Group further deepened cooperation with regional retail enterprises, such as GOME in Northeast China in the home appliance industry. It also entered into strategic cooperation with provincial-level supply and marketing cooperatives in places such as Chongqing, Jiangsu, and Anhui in the agricultural means of production industry, promoting fertilizer-grain integration to support the positive interplay between domestic circulation and international circulation of agricultural means of production. The Group also actively opened up cooperation with its own brands and resource-based enterprises. In respect of its own brand, the Group has made significant breakthroughs. Its self-designed brand "IDISSA" air conditioner has achieved mass production, with an order volume of over 16000 sets within two weeks of its launch; In the agricultural means of production industry, the Group has established independent and controllable production processes and operational management capabilities by launching the "Acephate" integrated production and marketing project. Through the construction of its own brand and the promotion of integrated production and marketing business, the Group has achieved the implementation of the B2F model of determining the procurement based on demand, the advancement based on demand and production based on demand, greatly improving the efficiency of the entire supply chain in urban and rural areas. Faced with new changes in the low-tier industry, the Group also built on new industries and categories on the basis of deepening its existing businesses. In the cleaning chemicals daily necessities sector, the Group is simultaneously expanding into high gross profit categories such as personal care, home cleaning, and beauty to further enhance the gross profit level and input-output efficiency; In the new energy sector, the Group has laid out the photovoltaic track and jointly built a distributed green energy industry platform with leading enterprises in the industry. With the increasing demand for operational efficiency and precise customer acquisition among merchants in the lower-tier retail market, ToB services are expected to further grow in the future. According to estimates from Frost & Sullivan and LeadLeo Research Institute, its market size is expected to reach 9.4 trillion yuan by 2027. It can be foreseen that the layout of these new industries and categories bears new growth points to the Group, and the potential to further enhance its gross profit level and market competitiveness. Member Service Capability Continues to Strengthen, Digital Construction Accelerates Huitongda Network has always regarded empowering and serving family-run retail stores in towns and villages as its basic business. The Group continuously improved its the capacity for serving members, and enhanced the stickiness and profitability of member stores. There are about 6.3 million couple stores nationwide, of which 75% are located in lower-tier markets. As a key component of the low-tier market, family-run retail stores demonstrate flexibility, adaptability, and strong vitality due to their small business scale and low cost investment. With rich experience and market insight, operators have established deep community emotional connections and loyal customer groups, which are important supports for store operation and the power of word-of-mouth communication. In a social environment with strong human touch, family-run retail stores not only provide commodity transactions, but also become places for community residents to communicate and express emotions. They have an irreplaceable position in the low-tier market and serve as the terminal for commodity circulation and the link for community cultural preservation and emotional connection. Therefore, for industrial Internet platforms such as Huitongda Network, in-depth understanding and empowering family-run retail stores is the key to expanding the low-tier market, improving the efficiency of the supply chain, building industrial ecology and promoting the integrated development of urban and rural areas. By providing digital tools, supply chain resources, marketing training, and other support, the Group helped family-run retail stores transform and upgrade, improved operational efficiency and profitability, and explored vast opportunities in the low-tier market. Data shows that in the first half of 2024, the Group's service business revenue increased by 12.0% year-on-year, SaaS+ subscription users increased by 5.1% year-on-year, paid SaaS+ users increased by 28.8% year-on-year, and store SaaS+ subscription revenue increased by 13.6% year-on-year. The growth of these data not only reflected a significant improvement in the Group's capacity for serving members, but also highlighted the enormous potential of the retail industry in the lower-tier market. To further improve the operational efficiency of member stores, the Group has developed and upgraded its system tools with a focus on "hot products+AI", and adhered to going deep into the front line to organize high-frequency and effective training and activities. At the same time, the Group continued to promote key customer service, expanded the network and coverage of member stores, providing better products, tools, marketing, training, and data empowerment for member stores. In respect of digital construction, the Group has always been at the forefront of the industry in building an industrial trading platform to help brand manufacturers reach the low-tier market, and deeply applying AI technology to optimize service efficiency. By launching functions such as "digital human livestreaming studio" and "multi-level marketing", the Group gradually opened up platform warehousing and logistics services to merchants, and cooperates with "production and marketing integration" to build an online order collection and production scheduling system. The application of these digital tools improved the operational efficiency of the company, and also brought more convenience and revenue to the member stores. In Summary Admist the current market environment where the omnichannel transformation wave of online and offline integration sweeping the retail industry in the low-tier market, Huitongda Network is proactively adapting to this trend and seizing unprecedented development opportunities by virtue of its unique supply chain integration, robust capacity for serving members, and forward-looking layout of digital construction. Through deepening strategic partnerships with leading brands in various industries, the Group has not only consolidated its existing market position, but also boldly explored new industries and categories, and successfully launched its own brand business. This series of measures significantly enhances its market competitiveness and lays a solid foundation for its long-term development. The sustained business innovation capability demonstrated by the Group is the key to its continuous progress in the market environment. This innovation capability is both reflected in the optimization and upgrading of existing businesses, and in the ability to keep a closer eyes on market change and timely capture emerging opportunities for continuous business model innovation to comply with market development. Looking ahead, the Group will stay true to its original aspiration and continue to focus on the three core strategic directions of supply chain optimization, member store empowerment, and digital upgrading, to further deepen industrial upgrading and digital transformation. On the path towards high-quality development, the Group is steadily forging ahead with richer returns for shareholders and better service experiences for customers, and advancing toward a great future. 30/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Huitongda Network Interim Report 2024: Service Revenue Up 12% Year-On-Year Amidst Industrial Upgrading with High Quality

EQS Newswire / 30/08/2024 / 09:47 UTC+8 On August 28th, Huitongda Network Co., Ltd. (9878. HK) released its financial report for the first half of 2024, when the company proactively adjusted its development strategy to focus on optimizing its industrial structure and promote high-quality business development. According to the financial report, Huitongda Network recorded a total revenue of 32.86 billion yuan and a net profit attributable to the parent company of 130 million yuan; The quality of operation has steadily improved, with a gross profit margin of 3.5%, an increase of 0.5 percentage points compared to the same period last year.Uncertainties in the global macroeconomy are on the rise and consumption growth falls short of expectations in the first half of 2024. The retail sales of consumer goods in China totaled RMB 23.6 trillion for the half year, with per capita disposable income of urban residents increasing by 4.6% and per capita disposable income of rural residents increasing by 6.8%, according to the National Bureau of Statistics of China.The income and consumption growth rate of rural residents in domestic lower-tier markets is better than that of urban markets, but demand is still under pressure in the short term. Given the severe situation, Huitongda Network takes "improving quality and efficiency in transformation and innovation" as its general principle for the year, actively adjusts its industrial structure and improves operational efficiency to further promote business transformation and upgrading.Huitongda Network, the industrial Internet leader exploring expansion into lower-tier retail market, served for family-run stores in villages and towns through the empowerment of digital technology and supply chain capacity. For one thing, the Group created a stable and efficient one-stop supply chain and provides multi-category transaction services; For another, by empowering upstream and downstream partners in the urban-rural industrial chain through digitization, it provided services such as SaaS+ services and merchant solutions. At present, the Group has formed a retail ecosystem covering 24,000 townships in 21 provinces and municipalities directly under the central government in China. Its main products focused on the "three high categories" of high product value, high offline experience, and high after-sales requirements, covering seven major categories of consumer electronics, household appliances, agricultural means of production, vehicles and auto parts merchandise, liquor and beverages, home building and renovation materials, and personal care.In the commerce business sector, the Group has steadily improved its supply chain capacity, achieving a revenue of 32.39 billion yuan during the reporting period. According to the financial report, the Group has over 246,000 registered member retail stores as of the end of June 2024, a year-on-year increase of 13.2%; Over 92,000 active member retail stores, a year-on-year increase of 19.3%. The revenue of member retail stores has increased to 43.8% compared to the same period last year, further strengthening the control over downstream channels.In constructing supply chain capacity, the Group focused on brand cooperation, integrated production and marketing, and market expansion in the first half of the year, improving the efficiency of the entire industry chain. In respect of brand cooperation, the company deepened cooperation with leading brands in seven major sectors including household appliances, consumer electronics, and vehicles and auto parts merchandise, while expanding cooperation with resource-based and regional retail enterprises; In respect of integrating production and marketing, the company has established an innovative supply chain model and taken the lead in incubating integrated production and marketing projects in the home appliance and agricultural means of production industries, greatly improving the efficiency of the supply chain and the output of commercial business value. Among them, the self-owned brand "IDISSA" air conditioner launched in the first half of the year exceeded 16000 sets of orders in just two weeks, setting the "ultimate cost-effectiveness" label for the lower-tier market. Moreover, the Group has expanded into areas such as home cleaning, personal care, and photovoltaics while consolidating existing business, striving to improve gross profit levels and promote sustainable growth.In the service business sector, the Group continued efforts to strengthen the capacity for serving members, achieving a revenue of 380 million yuan in the first half of the year, a year-on-year increase of 12.0%. According to the financial report, the Group accumulated over 127,000 SaaS+ subscription users in the first half of the year, a year-on-year increase of 5.1% and nearly 48,000 paid SaaS+ users, a year-on-year increase of 28.8%, along with store SaaS+ subscription revenue of RMB 310 million, a year-on-year increase of 13.6%. The loyalty of member retail stores further improved.Focusing on upgrading product value, the Group further strengthened its capacity for serving members during the reporting period. In product upgrades sector, the Group promoted further upgrading of SaaS+ products, gaining market recognition in efficiently empowering digital management of stores and targeted marketing strategy advice for members; In membership services sector, joint promotional activities were carried out with brand owners and manufacturers in the first half of the year, with a total of 6 national sales promotions, and more than 27,000 store-based personalized activities; In customer development sector, continuous progress has been made in the key customer service strategy, and deep cooperation has been established with over 60 domestic service enterprise customers, brand owners, and chain merchants.In respect of digital construction, the Group continued to upgrade its industrial trading platform in the first half of the year, launching functions such as merchant live streaming rooms and price inquiry and trading of products. It also promoted technological innovation and strengthened the application of cutting-edge technology to enhance the AI review of products and achieve automatic generation of product description, ensuring fast listing while improving service efficiency.Regarding the shareholder returns, the Group actively followed the government's initiative in the form of favorable returns to investors based upon the new "National Nine Articles" (short for Opinions on Strengthening Regulation to Prevent Risks and Promote High-Quality Development of Capital Markets, which consists of nine parts). In July, a proposal was passed to formulate a Shareholder Dividend Return Plan for the Next Three Years (2024-2026) and amend the Group's articles of association, opening a window for the implementation of the shareholder dividend return plan in the next three years.Since its listing, Huitongda Network stays committed to the mission of "making farmers' lives better", developing the low-tier market while promoting rural revitalization. On the one hand, the Group deepened the empowerment of rural talents and conducted training for over 20000 new farmers in the first half of this year; On the other hand, it fully integrated digital technology into the real economy in the low-tier market through applying digital technology in rural development. The Group's industrial Internet mode has been reported by the "People's Daily", "Xinhua News Agency" and other national media for many times during the reporting period. Meanwhile, its business value has also been recognized by the capital market after being included in the MSCI World Small Cap Index, and listed as the "Fortune China 500" for three consecutive years.Huitongda Network stated that looking ahead, the Group will adhere to sustainable and high-quality development by focusing on four core competencies: supply chain capability, brand operation capability, platform service capability, and organizational construction capability, to improve the operational efficiency of member retail stores, thereby promoting further upgrading of urban and rural industrial ecosystem, while promoting rural revitalization and high-quality development of digital villages. 30/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Modern Dental Group Increased 2024 Interim Dividend by 33% YoY, Accelerated Growth on Digital Cases with a 2-Year CAGR of 56%

EQS Newswire / 30/08/2024 / 09:53 UTC+8 RESULTS HIGHLIGHTS: ● The Revenue for the six months ended 30 June 2024 (“the Period”) was approximately HK$1,701.8 million, representing an increase of about 6.3% compared to the same period last year. Notably, the major European market accounted for 48.4% of the Group's total, with sales growing by 16.2% compared to the same period last year. ● The Gross Profit Margin for the Period was approximately 53.7%, with a gross profit of about HK$914.0 million, represents an increase of approximately 5.4% compared to the same period last year. ● The Group’s Adjusted EBITDA for the Period was approximately HK$388.6 million, representing an increase of approximately 5.1% as compared to the same period last year. ● The profit from the Group's core business for the Period was approximately HK$225.5 million, representing a growth rate of 7.2% compared to the same period last year. ● The Group’s Net Profit for the Period was approximately HK$214.4 million, representing an increase of approximately 1.9% as compared to the same period last year. ● With respect to the Group’s EBITDA and Net Profit for the Period, it should be noted that the figures reflect: (i) one-off cost in connection with potential acquisitions of approximately HK$2.8 million; and (ii) one-off cost in connection with Shenzhen and Vietnam production facility relocations of approximately HK$10.2 million. ● Basic earnings per share for the six months ended 30 June 2024 amounted to HK$22.59 cents. ● The Board declared an interim dividend of HK8.0 cents per ordinary share for the six months ended 30 June 2024. ● During the period under review, The Group’s digital solution cases (overseas and domestic) that are produced from its Mainland China production facilities increased to approximately 602,485 cases reflecting an increase of 61.1% as compared with the same period in 2023 as a result of our clients’ continued adoption of intra-oral scanners. (29 August 2024, Hong Kong) - Modern Dental Group Limited (hereinafter referred to as "Modern Dental Group" or "the Group", stock code: 03600.HK”), a leading global dental prosthetics provider, is pleased to announce the unaudited interim results for the six months ended 30 June 2024 (“the Period”). During the six months ended 30 June 2024, although the macro-economic environment continues to be challenging, the Group’s multi-dimensional strategies and comprehensive products portfolio, encompassing higher-priced and cost-effective dental treatments, enabled the Group to capitalize on market opportunities by capturing new customers and increase its sales volume, displaying the Group’s ability to outperform its competitors throughout the economic cycle. The consolidation trend of the dental prosthetics industry is clearly continuing, and with the addition of our Vietnam production facility and Dongguan Phase 2 production facility - the Group has further improved its market positioning. The Group’s continued sales increase represents a solid execution across each of the Group’s markets operationally and financially, illustrating the Group’s ability to deliver strong financial results in a relatively stable operating environment characterized by consistent order volume growth, competitiveness in the industry, and close relationship with its clients and customers. The Group’s underlying fundamentals continue to be solid and we are well-positioned to capture further opportunities going forward. European Business During the period under review, the European market recorded a revenue of approximately HK$822.9 million, representing an increase of approximately HK$112.9 million as compared with the six months ended 30 June 2023. This geographic market accounted for approximately 48.4% of the Group’s total revenue. The increase of revenue from the European market was attributable to the increase in sales order volume driven by the launch of new products, such as digital dentures, and our state-of-the-art digital workflows. The Group has been the frontrunner providing comprehensive digital solutions offerings, ranging from numerous minimal invasive and aesthetic prosthetic solutions to intra-oral scanners and clear aligners, and is well positioned to capture the opportunities arising from the accelerated digitalization trend of the dental industry. The Group continues to aggressively gain market share from international and domestic competitors through our established dental ecosystem solutions with a focus on education and digitalization, which is available within close proximity to our clients; effectively meeting our clients’ high expectations through our various onshore and offshore resources. North American Business During the period under review, the North American market recorded a revenue of approximately HK$385.3 million. This geographic market accounted for approximately 22.6% of the Group’s total revenue. Our clients’ interest surrounding digital dentistry continued to increase during the period. A significant portion of our business in the North America region comprises higher-end products manufactured domestically. With our centralized digital workflows and network oversight over our wide coverage of production units within the region, we are well positioned to support the customers’ needs through their digitalization journey, focusing on leveraging efficiencies and providing an enhanced customer experience throughout the network. Looking forward, the Group targets to utilize the Vietnam production facility to establish a new business unit specialized in serving mid/large scale dental clinic chains customers in the North American market. Greater China Business During the period under review, the Greater China market recorded a revenue of approximately HK$335.8 million. This geographic market accounted for approximately 19.7% of the Group’s total revenue. As a result of the increase in sales volume in the Mainland China market following the full implementation of the volume-based procurement policy in the Mainland China market gradually since the second half of 2023, our Mainland China business reported a sales growth of 9.5% in the Period compared to the same period last year but is offset by the depreciation of RMB against HK$ by 2.7%. However, this also led to aggressive promotions for dental implant treatments by Mainland China dental clinics in Hong Kong (which experienced a notable decrease in patient visits in Hong Kong). The Group is optimistic in its mid/long-term outlook for this market in particular where the latest procurement-related government measures are expected to (i) standardize the pricing of dental prosthetics and develop price transparency, which would level the playing field; (ii) allow the Group’s leading brand name and reputation to be a key consideration for its client and customer; and (iii) have the Group benefit from its large production team and its ability to allocate resources efficiently according to the customer or client. Australian Business During the period under review, the Australian market recorded a revenue of approximately HK$127.9 million representing an increase of approximately HK$3.6 million as compared with the six months ended 30 June 2023. This geographic market accounted for approximately 7.5% of the Group’s total revenue. The increase of revenue from the Australian market was predominately due to the increase in sales volume as a result of the increase in market share driven by the digitalization trend in dental industry which is partially offset by the depreciation of AUD against HK$ by 2.8% compared with the six months ended 30 June 2023. Through our various brands, which offer onshore-and offshore- made products, at multiple price points ranging from economy and standard to premium/boutique, the Group is able to effectively penetrate the entire Australian market. Future Prospects It is expected that the Group continues to consolidate the dental prosthetic market, and the Board is of the view that the consolidation trend is irreversible and clearly continuing. Therefore, notwithstanding any short- or medium-term challenges the global economy may face, the Board is confident that the Group is expected to outperform its competitors. In a year where some of the Group’s competitors had faced materially adverse issues, the Group continued to thrive and it is the Group’s ability to thrive during such uncertain economic conditions that give the Board comfort in its optimistic view of the Group. Going forward, the Group aims to reinforce its worldwide leading position through opportunistic transactions including strategic co-operations, acquisitions, joint ventures and/or partnerships, to further expand and complement our product-offering (in particular, our clear aligner products), distribution and sales networks which will in turn, drive our business expansion. The Group continues to grow into more than just a one-stop shop dental prosthetic provider, but a full dental ecosystem to support our customers. The Group’s investment in Dongguan phase 2 and Vietnam production facilities are expected to provide the Group with greater production solutions and optionality which will in turn, increase the Group’s level of research and development in further enhancing our production and products. Looking forward to 2024, with the Board’s extensive experience and determination to meet any short-term challenges, the Group is in an ideal position to take full advantage of, and will remain opportunistic in, any business opportunities whilst remaining cautious and prudent in safeguarding shareholders’ interests. About Modern Dental Group Modern Dental Group Limited (Stock code: 03600.HK) is a leading global dental prosthetics provider, distributor and consultant with a focus on providing custom-made prostheses to customers in the growing prosthetics industry. Our product portfolio is broadly categorized into three product lines: fixed prosthetic devices, such as crowns and bridges; removable prosthetic devices, such as removable dentures; and other devices, such as orthodontic devices, sports guards, clear aligners, and anti-snoring devices. Modern Dental Group has a global portfolio of respected brands, including Labocast, Permadental and Elysee Dental in Western Europe, YZJ Dental in China, Modern Dental Lab in Hong Kong, Modern Dental USA in the United States, and Southern Cross Dental in Australia. We have grown these brands by providing premium and consistent quality products and superior customer service. We have more than 80 service centers in over 23 countries and serve over 30,000 customers. 30/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Airdoc Technology 2024 Interim Results: Solid Growth in Revenue and Gross Profit

EQS Newswire / 30/08/2024 / 11:52 UTC+8 On August 28, Airdoc Technology (2251.HK) announced its 2024 interim results, demonstrating continued solid growth. In the first half of 2024, Airdoc Technology achieved revenue of RMB93.71 million, a year-on-year increase of 13.6%. Gross profit reached RMB53.76 million, with a gross profit margin of 57.4%. The Company achieved steady growth in both revenue and gross profit, further consolidating its leading position in the industry. As a global leader and pioneer in the field of retinal imaging AI technology, the Company has further enhanced the coverage and effectiveness of its health management services by continuously promoting the in-depth application of AI technology during the reporting period. Diversified strategies yield results, business growth accelerates steadily The Company has focused on its core business to achieve sustainable growth while promoting its diversified strategies. During the reporting period,the company's business covered three major segments: Airdoc Medical, Airdoc Health, and Airdoc Eye Health. Airdoc Medical and Airdoc Eye Health achieved revenue growth of 22.1% and 22.7% respectively. The significant increase in the number of customers and service sites has driven the expansion of the overall business. In the first half of the year, the number of customers increased to 418 and the number of active service sites increased to 5,950, representing a 78.63% increase year-on-year. The Company served 2.96 million people through its SaMD and health risk assessment solutions, identifying 15,842 significant positive cases, with a cumulative total of more than 70,000 significant positive cases identified, making a significant contribution to the early detection and treatment of major diseases. The Company has further enhanced the accessibility of healthcare services through the widespread application of Airdoc-AIFUNDUS (1.0). The number of active service sites covered in hospitals reached 244, reflecting a year-on-year increase of 70.6%, while the number of active service sites covered in primary care organizations reached 1,533, a year-on-year increase of 192.0%. The number of tests has grew significantly in both hospitals and primary care organizations. In addition, the Company deployed AI solutions in more than 296 medical check-up centers nationwide, and the reorder rate of software products in some medical check-up centers exceeded 50%. Global market expansion is also accelerating at the same time. After obtaining market access in the CE27 countries of the European Union, the company’s products have entered markets such as Malaysia, Singapore, Thailand, the United Arab Emirates and South Africa, and the revenue of international business has increased by 17% year-on-year. AI technology breakthroughs, intelligent upgrade of visual training Driving the company’s growth are the continuous iteration and upgrading of products, along with investment in research, which act as dual engines. Ensuring long-term competitiveness and meeting the increasingly complex and diversified needs of our customers are the necessary safeguards for success. These include, but are not limited to, the postoperative refractive error prediction method developed by the Company in collaboration with the Eye, Ear, Nose and Throat Hospital of Fudan University, which has been published in the Journal of Cataract and Refractive Surgery (JCRS), providing ophthalmologists with a more reliable clinical reference. A semi-supervised deep learning model developed in collaboration with Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, has also achieved remarkable results and was published in iScience, a sub-journal of Cell. The model significantly reduces the cost of data labeling while maintaining excellent classification results, providing a new solution for clinical applications. During the reporting period, the Company also successfully developed AI eye movement technology based on ordinary RGB cameras and integrated it into its vision training AI products, forming a unique AI vision training digital therapy. The upgraded version of the vision training AI products added AI eye movement and AI training guidance functions, and launched the AI VisionBox for the optometry market. In addition, the AIFUNDUS-M multimodal fundus camera has completed its development and registration, and its hardware, software, algorithms and solutions have been fully upgraded. Meanwhile, the Company is actively advancing the research and development of non-invasive phototherapy device to continuously expand its product line. Firm commitment to advancing technology and integrated diagnostics for public benefit Airdoc Technology understands that corporate excellence also stems from the deep practice and relentless pursuit of social responsibility. Therefore, the company actively participates in public welfare programs, such as the large-scale chronic disease screening program in Yangchun City, Guangdong Province, which provides free chronic disease screening services for 10,000 citizens. Additionally, the company assists the laboratory sponsored by BGI in conducting risk monitoring for high-altitude sickness. During the reporting period, Airdoc's public welfare covered about 100,000 people. Looking ahead, Airdoc Medical Technology will continue to deepen the application of AI technology in the field of medical and healthcare, and promote the wide application of General Artificial Intelligence (AGI) in assisted diagnosis, disease detection and personalized medical advice, further optimize its product portfolio, continue to expand its market channels, and enhance its global market coverage by strengthening its technological research and development and production capabilities. With the improvement of the laboratory in Changsha manufacturing base, the Company will maintain its competitive advantages in the areas of AI-based myopia prevention and control products for fundus retina, myopia prevention and control products and vision training AI products. Airdoc Technology is firmly promoting the strategy of integrated diagnosis and treatment from detection to diagnosis, driving the comprehensive upgrade of the AI health industry, creating greater value and possibilities for society, and committed to the mission of making healthcare accessible and affordable for everyone. 30/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Ficus Technology Holdings Limited (8107.HK) Entering into a Cooperation Agreement with the subsidiary of China Supply and Trade Group to Synergise Channel and Supply Chain Resources

EQS Newswire / 29/08/2024 / 23:30 UTC+8 Ficus Technology Holdings Limited(Incorporated in the Cayman Islands with limited liability) (Stock Code: 8107) Entering into a Cooperation Agreement with the subsidiary of China Supply and Trade Group To Synergise Channel and Supply Chain Resources (Hong Kong - 29 August 2024) Innovative supply chain management service provider – Ficus Technology Holdings Limited (“Ficus Technology” or the “Company”, together with its subsidiaries, the “Group”) is pleased to announce that on 29 August 2024, Ficus Discovery (www.ficusdsc.com, “Ficus Discovery Platform”), the e-commerce platform operated by the Group is collaborating with Beijing New Cooperation Ruida Trade Co., Ltd.* (“Beijing Ruida”) for a period of three years. As a direct wholly-owned subsidiary of China Supply and Trade Group and an indirect wholly-owned subsidiary of China CO-OP Group Co., Ltd., Beijing Ruida is primarily engaged in provision of supply chain services, operation of supermarket and other business in the retail industry. Leveraging its supply chain resources, including access to local products and local brands as well as its extensive supermarket and retail network, Beijing Ruida will provide products and supply chain services to Ficus Discovery Platform. This strategic partnership will allow both parties to synergise their channel resources, enhance product diversity and expand customer base across both online and offline channels. About Ficus Discovery Platform Ficus Discorvery Platform is an e-commerce platform operated by the Group, utilizing a disintermediation model to establish direct connections between manufacturers and consumers (“M2LC”), thereby facilitating transactions and cultivating a long-term loyal customer base. Leveraging the Group’s extensive supply chain resources, innovative supply chain management solutions, digital marketing capabilities, authentication and traceability technologies, the Ficus Discovery Platform is well-positioned to be a trustworthy gateway for brands and manufacturers to access target customers. Mr. Chan Ting, Chairman and Executive Director of Ficus Technology Holdings Limited comments: “Ficus Discovery Platform is pleased to work with Beijing Ruida on providing products to consumers in both the e-commerc platform we operated and the retail channels of Beijing Ruida’s platform. The collaboration not only enables Ficus Discovery Platform to diversify its product offerings but, more importantly, provides the Group with valuable access to the sales channels of the China Supply and Trade Group. We are confident that this collaboration will significantly elevate Ficus Discovery Platform's presence among consumers, establishing it as the preferred destination for daily necessities. Additionally, this partnership will amplify the brand value for both parties, driving mutual growth and market influence.” - END - About Ficus Technology Holdings Limited(8107.HK) Ficus Technology Holdings Limited (formerly known as Vision International Holdings Limited) is an innovative supply chain management service provider, mainly focuses on the sales of apparel products with the provision of supply chain management services. The Group had advanced supply chain management service to include anti-counterfeit, traceability and marketing functions for brand protection on both the apparel and other products. File: 8107_Press Release_EN_20240829_Final 29/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Newborn Town sees a net profit growth of 28% to RMB 388 million, total revenue surpassed 65% for the first half of 2024, whilst the MENA market revenue surged by over 44%

EQS Newswire / 30/08/2024 / 07:14 UTC+8 Newborn Town sees a net profit growth of 28% to RMB 388 million, total revenue surpassed 65% for the first half of 2024, whilst the MENA market revenue surged by over 44% On August 29, Newborn Town (09911. HK) unveiled its interim results for the first half of 2024, demonstrating significant growth in various key operational indicators. The improvement was driven by its skyrocketing pan-audience social networking business and further expansion in the MENA market. According to the announcement, Newborn Town reported a total revenue of RMB 2,272 million for the first half of 2024, marking a substantial 65% period-on-period increase. Net profit for the period reached RMB 388 million, up 28% period-on-period. Profit attributable to the owners of the Company was RMB 225 million, reflecting a 21% period-on-period rise. Adjusted EBITDA totaled at RMB 448 million, demonstrating a 29% period-on-period increase. The social networking business segment attained robust growth, achieving revenue of approximately RMB 2,070 million, marking a 67% growth period-on-period. Additionally, the innovative sector made significant progress, recording revenue of around RMB 202 million, reflecting a 54% period-on-period growth. Notably, the Company's long-term investment in the MENA region has been yielding positive feedback. The capability for "product replication "has been further strengthened, with new products represented by SUGO rapidly maturing, thus bringing fresh growth momentum to the Company. As one of the major markets, the MENA market has consistently been the core focal point of the Company’s strategic implementation of localization strategy. Through years of in-depth regional operations, Newborn Town has built up a comprehensive regional organization, nurtured a local team of employees, and forged strong connections with local creators and partners. The benefits brought about by Newborn Town's localization efforts are becoming increasingly evident. For the first half of 2024, the MENA market contributed over 50% of the company's social networking business revenue, with the core products recording a 44% period-on-period increase. The MENA region has also been the market for Newborn Town's new business incubation. Products with high potential, such as TopTop and SUGO, have been successfully scaled up from inception as their business models were verified for global market expansion. This August, Saudi Arabia's Ministry of Investment granted Newborn Town a Regional Headquarters (RHQ) license, making it the world's first social entertainment company to establish a regional headquarter in Saudi Arabia. This move further consolidates Newborn Town's efforts in the MENA region. Under the RHQ program, Newborn Town will aim to build a trustworthy enterprise in the MENA region through close connections with governments, active engagement in community development and charitable activities, serving the local populace and building an ecosystem. While continuously widening the moat with its localization strength, Newborn Town has also achieved significant breakthroughs in product operation, starting to achieve the goal of replicating the popular apps that generate tens of millions of dollars in monthly revenue. After MICO, the companion-based social app SUGO has reached the target. Newborn Town's operation strategy, centered on cultivating the "Bushes" housing apps with diverse features, has been developed through a deep understanding of users' specific social and entertainment needs. Under this strategy, Newborn Town's strength in app operation has steadily advanced, alongside enhancements in the middle platform mechanism. Moreover, the company's aggregated localized operation resources have hastened the emergence of hit apps by facilitating swift product launches, cost-effective trial and error testing, and highly efficient verification. SUGO and TopTop, the new apps under Newborn Town, have both experienced explosive revenue growth. SUGO, for example, has achieved an over 250% period-on-period increase in revenue. In July, SUGO contributed the majority revenue to Newborn Town among the apps. TopTop, the social gaming platform with a double period-on-period revenue increase in the first half, was featured as a recommendation on the Apple App Store in May, reaching users across dozens of countries and regions, including Saudi Arabia, the United Arab Emirates, and Oman. The first-mover products, such as MICO and YoHo, have also made significant strides. MICO, TopTop, SUGO, and YoHo all ranked on Sensor Tower's Top 10 highest-grossing social apps in MENA from January to May 2024. According to the announcement, the company will persist in its pursuit of creating successful products in increasingly specialized niches and duplicating more apps that yield monthly revenues in the tens of millions of US dollars. Beyond its achievements in pan-audience social networking business, Newborn Town’s other business segments have also seen notable progress. HeeSay, the LGBTQ+ online community, has strengthened its global brand presence through more refined in-app operations. Since early this year, this platform has launched a series of offline events in Bangkok, Ho Chi Minh City, Los Angeles, etc., fostering a stronger sense of community among users. These efforts have contributed to an increase in business scale of approximately 25%. In addition, the company has continued investment in developing quality games. In the first half of 2024, Newborn Town's quality games achieved a recharge of RMB 387 million, up 393% period-on-period. Its flagship title, Alice's Dream: Merge Games, secured a spot among Sensor Tower's top 30 Chinese mobile games in overseas revenue for May and June. Overall, Newborn Town has made significant strides across key markets and various business segments in the first half of 2024. The company has reinforced the validity of its business models in the social sector, bolstering the competitiveness of its new products and injecting new growth catalysts. Moving forward, Newborn Town aims to delve deeper into the social entertainment realm, gaining a foothold in MENA and expanding globally to create positive emotional values. File: FINAL-赤子城科技公布中期業績_en_20240829 30/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Kazakhstan’s Kaspi.kz (KSPI) Eyes Acquisition of Uzbekistan’s Humo Payment System: A Strategic Move Amidst Regional Expansion

EQS Newswire / 29/08/2024 / 15:38 UTC+4 Kaspi.kz (KSPI), the fintech giant from Kazakhstan, has announced its intention to participate in the privatization of Humo, one of Uzbekistan’s leading payment systems. This move is seen as a significant step in the company’s broader strategy to expand its footprint across Central Asia, further solidifying its position as a regional financial leader.The proposed acquisition of Humo would mark Kaspi.kz’s first major venture into the Uzbek market, a region that has been attracting increasing attention from global investors due to its rapid economic reforms and growing consumer base. With a robust digital ecosystem already in place in Kazakhstan, Kaspi.kz is well-positioned to leverage its technological expertise and customer-centric approach to drive growth in Uzbekistan.According to Paulius Stankevicius, CEO of Stankevicius Alternative Investment Banking, a leading global investment advisory firm, Kaspi.kz’s interest in Humo is a strong signal for the banking industry in Central Asia. Stankevicius, whose firm advises some of the world’s top financial institutions, remarked, “Kaspi.kz has consistently demonstrated its ability to innovate and capture market share through its integrated platform that combines payments, marketplace services, and financial products. Their move into Uzbekistan signals a growing confidence in the region’s economic potential and will likely spur further investments in the fintech sector.” Sean Chin MQ, investment manager of Olritz Financial Group , with over 10 years of experience in hedge fund management, shared this perspective. His firms, specializing in asset management and financial licensing across Asia and Australia, manage $149 million USD in assets. “The entry of a fintech leader like Kaspi.kz into the Uzbek market is a significant milestone. Uzbekistan presents a unique opportunity for growth, and Kaspi.kz’s strategic move will likely encourage further investments and innovations in the region’s financial services,” said Sean Chin MQ. This view is reinforced by Mikhail Lomtadze, CEO and co-founder of Kaspi.kz, who in a recent statement emphasized the strategic importance of entering the Uzbek market. “Uzbekistan represents a significant growth opportunity for us. The privatization of Humo presents a unique chance to replicate our success in Kazakhstan by offering a comprehensive ecosystem of financial services that cater to the evolving needs of Uzbek consumers,” Lomtadze noted.Industry analysts believe that Kaspi.kz’s expansion into Uzbekistan could serve as a catalyst for further consolidation in the region’s financial sector. By acquiring Humo, Kaspi.kz would gain access to a well-established payment infrastructure and a growing customer base, positioning itself as a key player in the Uzbek financial market.Moreover, this move could also set the stage for increased competition among regional and global fintech companies looking to capitalize on Uzbekistan’s ongoing digital transformation. As Uzbekistan continues to open its doors to foreign investment, the entry of a major player like Kaspi.kz could accelerate the development of the country’s financial ecosystem, providing consumers with greater access to innovative financial services.In conclusion, Kaspi.kz’s strategic interest in Humo is not only a testament to the company’s ambition but also a positive sign for the broader banking industry in Central Asia. As regional economies continue to grow and modernize, the involvement of established players like Kaspi.kz will be crucial in driving the next phase of financial innovation and inclusion. Media Contact Stankevicius MGM pr@stankeviciusmgm.com 29/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

DPC Dash Ltd 2024 Interim Financial Results

EQS Newswire / 29/08/2024 / 10:29 UTC+8 DPC Dash Ltd announces 2024 Interim Financial Results. 29/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Trio Industrial Electronics Group’s revenue for the six months ended 30 June 2024 amounted to HK$389.2 million; Continue to Develop ‘Greater Asia Sustainable Energy Business Circle’

EQS Newswire / 28/08/2024 / 22:57 UTC+8 Trio Industrial Electronics Group's revenue for the six months ended 30 June 2024 amounted to HK$389.2 million; Continue to Develop ‘Greater Asia Sustainable Energy Business Circle’ [Hong Kong – 28 August 2024] Trio Industrial Electronics Group Limited (“Trio Group” or the Group”, Stock code: 1710), a leading manufacturer and distributor of advanced industrial electronic components and products in Hong Kong, is pleased to announce the consolidated interim results of the Company and its subsidiaries (the “Group”) for the six months ended 30 June 2024 (“the Period”). During the Period, Europe and North America continued to be the Group’s major markets, contributing 86.2% and 7.8% of total revenue respectively. The major markets faced economic growth slowdowns caused by challenging business conditions, including high interest rates, currency depreciation, and geopolitical tensions. Customers struggled to manage surplus inventories, requiring extended efforts to reduce them amid stagnant end-user sales. Moreover, improvements in supply chain logistics and shorter delivery times encouraged customers to scale back surplus inventory levels, thereby reducing product demand. Consequently, the Group’s revenue for the Period decreased by 31.2% to approximately HK$389.2 million as compared with the corresponding period of 2023. Gross profit decreased by 43.2% year-on-year to approximately HK$67.6 million. Gross profit margin was 17.4% The Group reported a loss of approximately HK$ 25.9 million for the Period. In terms of business development, the Group’s order backlog indicates strong demand for its products, driven by a growing emphasis on health awareness, digital transformation, and the transition to sustainable energy. In addition, the Group strategically allocated additional resources to explore new opportunities in the new energy sector. The Group’s involvement in new energy initiatives included the production of essential electronic components for solar and wind power applications, as well as the development of electric vehicle chargers under our self-owned renowned “Deltrix” brand. Concurrently, in alignment with China’s influential “Belt and Road” initiative, the Group actively expanded its presence in Central Asia, notably inaugurating its first electric vehicle charging station in Almaty, Kazakhstan. The Group has been able to maintain a healthy financial position, with cash and bank balances (including restricted bank deposits) amounted to HK$120.1 million (31 December 2023: HK$77.5 million) and a current ratio at 2.6 times as at 30 June 2024. (31 December 2023: 2.9 times) Mr. Cecil Wong, the Chairman of Trio Industrial Electronics Group Limited said, “Looking forward to the second half of this year, we remain cautiously optimistic about the challenges in the business environment. Meanwhile, we also expect abundant opportunities in Central Asia with the positive development in relation to China’s ‘Belt and Road’ initiative. The Group’s overarching vision is to develop a ‘Greater Asia Sustainable Energy Business Circle’, fostering collaboration and sustainable growth across the region. To achieve this, we extend to establishing a solid presence in Uzbekistan, Hong Kong, and Southeast Asia by providing comprehensive solutions for electric vehicle charging. The Group will also establish more electric vehicle charging stations in Almaty, Kazakhstan. We aim to create an ecosystem that includes electric vehicle charging facilities, advertising services, intelligent e-commerce, car washes and convenience stores at these locations.” Mr. Wong continued, “Additionally, the Group will continue to invest in cutting-edge technologies to enhance production efficiencies and capabilities in its production facilities. Through these focused initiatives, the Group aims to strengthen its market position, harness industry growth, and uphold its dedication to excellence while meeting the diverse needs of its stakeholders.” About Trio Group Trio Industrial Electronics Group is a manufacturer and distributor of advanced industrial electronic components and products in Hong Kong with nearly 40 years of industry experience. It is also the first Hong Kong-based industrial electronic company awarded with the Industry 4.0 maturity certificate - Industry 4.01i level. The Group’s major products include smart chargers, electro-mechanical product and switch-mode power supplies, which are widely used in smart city systems, medical and healthcare sector, as well as renewable energy field. The Group has built up a good reputation and become a trusted supplier to various international well-known brands. The majority of its clients are from Europe and the US while some from Southeast Asia and PRC. In addition, the Group and its partner have developed their own EV charger solution - Deltrix since 2017, which has been launched in the European market in response to the global efforts to develop smart economies. This press release is issued by DLK Advisory Limited on behalf of Trio Industrial Electronics Group Limited. For more details, please contact: Skye Shum - IR Manager skyeshum@triohk.com.hk PR media: DLK Advisory pr@dlkadvisory.com File: Trio Industrial Electronics Group's revenue for the six months ended 30 June 2024 amounted to HK$389.2 million; Continue to Develop ‘Greater Asia Sustainable Energy Business Circle’ 28/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Uni-Bio Science Group Limited Announces 2024 Interim Results

EQS Newswire / 28/08/2024 / 19:52 UTC+8 Achieved Record High Revenue of HK$273.6M and Net Profit of HK$67.4M Further Penetration to Osteoporosis, Ophthalmology, and Medical Aesthetic Device Markets (28 August 2024 – Hong Kong) A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred to as the “Group”, stock code: 0690.HK), is pleased to announce its interim results for the six months ended 30 June 2024 (the “Period”). Key Accomplishments in the First Half of 2024 During the Period, the Group achieved a spectrum of accomplishments, for both of its marketed products and innovative biologics. The key highlights include: The Group’s revenue achieved an increase of 9.5% year-on-year (“YoY”) to approximately HK$273.6 million, whilst improving gross profit margin by 4.7 percentage points to 84.3%. Sales of Pinup® performed well, registered an increase of 12.8% YoY. The Group’s newly launched product Bogutai® achieved sales of HK$18.8 million in just four months, exceeding initial expectations. The Group achieved a record-breaking profit of approximately HK$67.4 million for the Period, representing a significant increase of 71.0% YoY, underscoring the Group’s effective strategies and operational efficiency. In January 2024, the China National Medical Products Administration (“NMPA”) granted official approval for Bogutai®’s marketing launch, marking a pivotal milestone for the Group in orthopedic disease management. Sales of Bogutai® commenced in the first half of 2024. With its superior safety profile and competitive pricing, Bogutai® promises to revolutionize global drug administration, making it more accessible and patient-friendly. In January 2024, the NMPA accepted the marketing application for Diquafosol Sodium eye drops, marking a significant advancement for the Group's ophthalmology drug portfolio. Diquafosol Sodium is anticipated to receive marketing approval in the first quarter of 2025, complementing the existing ophthalmic drug portfolio and becoming one of the first BFS Diquafosol products to be listed. The Group officially launched its first advanced skincare raw material product, Skbrella™ FN, with sales contributions expected to begin in the second half of 2024. The Group is leveraging endorsements from key opinion leaders (KOLs) in dermatology and capitalizing on the synergistic effects of Skbrella™ FN and EGF to enhance the brand's professionalism and market appeal. The Group is dedicated to the research and promotion of isavuconazonium sulfate, providing more effective antifungal treatment options for patients worldwide and improving their quality of life. During the Period, the Group completed the pharmaceutical research and is preparing to conduct pre-Bioequivalence studies, with the official market launch expected in the first half of 2027. In May 2024, the Group cooperated with Great Bay Bio (GBB) and Pebble Accelerator, a subsidiary of Tigermed to joint development of innovative weight reduction drugs, aiming to revolutionize the treatment of obesity. Through this collaboration, we seek to establish a comprehensive ecological industry chain, spanning from target discovery to antibody generation, druggability verification, process development, clinical pipeline, and ultimately, commercialization. Interim Results For the Period, the Group recorded revenue of approximately HK$273.6 million, representing an increase of 9.5% YoY. The increase in revenue was mainly attributable to the sales growth of Pinup® and the Group’s newly launched product Bogutai®. Pinup® recorded an increase of 12.8% in revenue from approximately HK$124.8 million to approximately HK$140.9 million for the Period. The increase was attributable to the successfully re-selected for the centralized procurement and the procurement validity period is set for two years. The Group launched Bogutai® in March 2024 and it made an immediate financial contribution, achieving sales of HK$18.8 million in just four months. During the Period, revenue generated from GeneTime® was approximately HK$91.3 million, representing a decrease of 4.8% YoY, mainly due to the more cautious procurement strategies adopted by public hospitals due to stricter governance. Yet, the Group continues to diversify its sales channel, such as e-commerce platforms, online hospitals and pharmacies. GeneSoft® recorded a decrease in revenue from approximately HK$22.3 million to approximately HK$18.9 million, representing a decrease of 15.4% YoY. During the Period, revenue from Boshutai® declined from approximately HK$6.9 million to approximately HK$3.8 million, representing a decrease of 45.7%. Gross profit was approximately HK$230.6 million, representing an increase of 16.0% as compared with approximately HK$198.9 million for the first half of 2023. Gross profit margin increased by 4.7 percentage points YoY to 84.3%, which was attributable to the Group’s ongoing efforts in optimizing its supply chain and effectively lowering the procurement cost of API. The Group kept a tight rein on general and administrative expenses, which only accounted for 8.7% of revenue for the Period as compared with 9.4% for the same period last year. Selling and distribution expenses for the Period also decreased to 42.8% of revenue from 50.5% that of the same period last year, mainly due to the marketing expenses of Pinup® decreased and the Group’s further optimization of its salesforce. The R&D expenses increased by 77.9% YoY to approximately HK$20.9 million and the amount was in step with the Group’s product research status. The Group achieved a record-breaking profit of approximately HK$67.4 million for the Period, representing a significant increase of 71.0% YoY. The substantial profit increase, driven by the launch of a new drug, the organic growth of marketed drugs, effective marketing strategies, strict cost control and ongoing supply chain optimization. This indicates that the Group is on the right path for sustainable profit growth. Prospects With advancements in biotechnology and strong governmental backing, the pharmaceutical landscape in China is poised for significant growth with a compound annual growth rate (“CAGR”) of 7.5% from 2024 to 2032, according to Imarc Group. Alongside traditional pharmaceuticals, the aesthetic medical sector is gaining prominence in the market. Forecasts indicate that the aesthetic medical market is set to sustain a CAGR growth of 10% to 15% between 2024 and 2027, primarily attributing to the increasing emphasis on beauty standards and the increased spending in this domain, particularly by individuals with moderate to high incomes. The two sectors are the Group’s focus, showcasing massive expansion opportunities for the Group. Looking forward, Mr. Kingsley Leung, Chairman of Uni-Bio Science said, “We are committed to establishing a highly commercial-driven and specialized boutique R&D platform where we tightly integrate research and production under one roof. Our focus is on growing our existing products and launching new high value generic and aesthetic medical products, which we believe will continue to provide strong cash flow in the short term and support the Group’s ongoing R&D on proprietary biopharmaceutical products. This includes expanding into new areas, such as best-in-class biologics for ophthalmology and obesity. In early July 2024, we have partnered with Chongqing Minji Medical Device Co., Ltd. to tap into the medical aesthetic device sector. This collaboration grants us exclusive distribution rights for their premier products and allows us to co-develop medical device products leveraging the Group's patented core ingredient, Skbrella™ FN. This joint initiative aims to introduce China's first batch of class II medical devices utilizing fibronectin, bolstering the Group's leadership in skincare and medical aesthetics. We expect to generate over RMB30 million annually in revenue from the aesthetic medical segment within the next two to three years. To boost product awareness and market shares, we have implemented an omnichannel strategy by collaborating with internet hospitals, establishing an official GeneTime® flagship store on JD.com and partnering with over 200 online distributors. In terms of offline efforts, we have partnered with top national chain stores and retailers renowned for strong brand presence and customer trust, as we believe this provides additional opportunities for the Group to engage more potential customers. These efforts aim to further bolster product sales and establish a robust foundation for the future launch of upcoming products. To support our upcoming sales and diversified product range, our new factory in Dongguan, Guangdong, has completed construction. The factory is expected to produce up to 19 million units per year of the Group's signature products, GeneTime® and GeneSoft®, representing an annual output value exceeding RMB 1 billion. This factory also features a BFS packaging line for the production of single-dose GeneSoft® and Diquafosol Sodium Eye Drops. The BFS packaging research and archival filing are expected to conclude by 2025, with the launch of GeneSoft® and Diquafosol Sodium Eye Drops in BFS packaging anticipated in 2026.” About Uni-Bio Science Group Limited Uni-Bio Science Group Limited is principally engaged in the research and development, manufacture and distribution of pharmaceutical products. The research and development centre is fully equipped with a complete system for the development of genetically-engineered products with a pilot plant test base which is in line with NMPA requirements. The Group also has two GMP manufacturing bases in Beijing and Shenzhen. The Group also has a highly efficient commercialization platform and marketing network. The Group focuses on the development of novel treatments and innovative drugs addressing the therapeutic areas of endocrine such as diabetes and osteoporosis, ophthalmology and dermatology. Uni-Bio Science Group Limited was listed on the Main Board of the Hong Kong Stock Exchange on November 12, 2001. Stock code: 0690. For further information, please contact: ir@uni-bioscience.com 28/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Ficus Technology Holdings Limited (8107.HK) Entering into a Cooperation Agreement with Shenbei Community Service Centre Co-nurturing Target Customers in Local Communities

EQS Newswire / 28/08/2024 / 01:09 UTC+8 Ficus Technology Holdings Limited (Incorporated in the Cayman Islands with limited liability) (Stock Code: 8107) Entering into a Cooperation Agreement with Shenbei Community Service Centre Co-nurturing Target Customers in Local Communities (Hong Kong - 27 August 2024) Innovative supply chain management service provider – Ficus Technology Holdings Limited (“Ficus Technology” or the “Company”, together with its subsidiaries, the “Group”) is pleased to announce that on 27 August 2024, the Group has entered into a strategic cooperation agreement with the Shenbei Hao He Er Community Service Centre in Shenbei New District, Shenyang City* (瀋陽市瀋北新區瀋北好賀兒社會服務中心,”Shenbei Community Service Centre”) for a period of three years. With a mission of “Supporting Enterprises and Benefiting Citizens,” Shenbei Community Services Centre is deeply rooted in local communities, offering comprehensive services and solutions to local residents. Through various community events and interactions, Shenbei Community Services Centre gains deep understanding of local needs and consumption trends, positioning it as a trustworthy gateway to access local consumers. Through this collaboration, Shenbei Community Services Centre will promote Ficus Discovery Platform (“Ficus Discovery Platofrm”, www.ficusdsc.com), the e-commerce platform operated by the Group and products it offers. A wide range of products, including apparel, daily necessities, and cosmetics, will be offered for sale in Shenbei New District, Shenyang City. About the Ficus Discovery Platform The Ficus Discorvery Platform is an e-commerce platform operated by the Group, utilizing a disintermediation model to establish direct connections between manufacturers and consumers (“M2LC”), thereby facilitating transactions and cultivating a long-term loyal customer base. Leveraging the Group’s extensive supply chain resources, innovative supply chain management solutions, digital marketing capabilities, authentication and traceability technologies, the Ficus Discovery Platform is well-positioned to be a trustworthy gateway for brands and manufacturers to access target customers. Mr. Chan Ting, Chairman and Executive Director of Ficus Technology Holdings Limited comments: “This is a mutually beneficial collaboration, allowing the Ficus Discovery Platform and the Group’s innovative supply chain management solutions to further expand its customer base, offering genuine products to local communities through community purchasing and other means. Leverage on the local knowledges provided by Shenbei Community Service Centre and the bonding influences of local residents, Ficus Discovery Platform would have the opportunity to nurture a group of loyal and long-term customers and thus enhance the sustainability and diversify the income stream of the Group.” - END - About Ficus Technology Holdings Limited(8107.HK) Ficus Technology Holdings Limited (formerly known as Vision International Holdings Limited) is an innovative supply chain management service provider, mainly focuses on the sales of apparel products with the provision of supply chain management services. The Group had advanced supply chain management service to include anti-counterfeit, traceability and marketing functions for brand protection on both the apparel and other products. File: 8107_Press Release_EN_20240827_FINAL 28/08/2024 Dissemination of a Marketing Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

TOT BIOPHARM (1875. HK):Steadily Expanding CDMO Project Pool with Both Certainty and Growth Potential

EQS Newswire / 26/08/2024 / 21:30 UTC+8 On August 7th, the Hang Seng Indexes Company Limited (HSIL) announced that biotech stocks have begun to show signs of improvement recently, benefiting from policy support and three consecutive months of capital inflows. With the introduction of more policies, the HS HK-listed Biotech Index has outperformed the market since July. Obviously, the positive changes revealed in HSIL’s article provide investors with a new perspective, which may also indicate that the entire pharmaceutical sector is entering a new turning point. Against the backdrop of the entire sector still being undervalued, pharmaceutical companies have marched into the financial reporting season these days, providing a window for the market to evaluate their value and predict future development. TOT BIOPHARM COMPANY LIMITED (1875. HK) (hereafter referred to as TOT BIOPHARM), which submitted its interim report recently, has shown impressive business performance. So how should we view this report card of the company? 1. Financial Report Highlights: Significant Transformation Results to Achieve A Turnaround The highlights revealed in the company's financial report can be summarized from the following aspects. Firstly, there is strong revenue growth and impressive results in turning losses into profits. In the first half of the year, TOT BIOPHARM reported operating revenue of 520 million yuan, a year-on-year increase of 59%, showing the strong growth momentum of the company's overall business. Among them, the growth in CDMO/CMO revenue is especially noteworthy, rising up to 144% year on year to 114 million yuan, and the product sales revenue reached 400 million yuan, a year-on-year increase of 44%, mainly by ongoing strong sales of core product Pusintin® (bevacizumab injection), demonstrating the solid foundation of the company's core business. It is worth noting that the company achieved a turnaround from loss to profit during the period, with a net profit of 31.559 million yuan in the first half of the year. This transformation not only reflects the profitability of the company's business, but also enhances market confidence in its future development. Secondly, there stands the company's excellent performance to generate revenue. The company's ability to generate revenue continues to strengthen, and the net cash flow from operating activities continues to show a positive trend. The data shows that the net cash flow from operating activities of 27.801 million yuan in the first half of the year presents the company's excellent cash flow management and capital operation capabilities. The core highlight of this report lies in the significant achievements of the company's strategic transformation. This is directly reflected in the strong growth of CDMO/CMO business. In the first half of the year, this business segment achieved a revenue of 114 million yuan, a year-on-year increase of 144%. It can be seen under the exponential growth that the company has successfully nurtured explosive growth points. Secondly, the transformation fruits are also reflected in the significant increase in the company's CDMO projects and the certainty of future growth. According to the financial report, the company added 20 new projects in the first half of the year, bringing the total to 115 projects. Among the new projects, 17 were ADC; In the meantime, 2 new pre-BLA (pre-biologics license application) projects have also been added, with a total of 8 in process. These projects will be directly linked to the commercial production of future products, providing the company with a clear path for performance growth and enormous commercial potential. In addition, the company’s backlog reached184 million yuan, a year-on-year increase of 104%. This remarkable achievement not only proves the strong driving force of the company's business, but also provides a guarantee for the stable growth of its future revenue. Besides, TOT BIOPHARM also features a firm determination and strategic vision for enterprise transformation in talent allocation and team building. TOT BIOPHARM has realized rapid expansion of its professional talent team in the CDMO field, with its talent structure constantly being optimized. According to the financial report, the number of CDMO team members increased by 29% to 492 compared to the same period last year, accounting for 86% of the total number of employees in the group. Meanwhile, in its core niche of ADC CDMO, its team size has also reached a year-on-year increase of 27%. This series of data reflects the company's emphasis and investment in CDMO business. Finally, the transformation achievements are also reflected in the continuous acceleration of the company's quality management system and multiple international recognition. High standard of quality management ensures the high standards and quality of the company’s products and services. Its quality management system can meet the GMP standards of China, the United States, and Europe, and has been widely recognized by the domestic and foreign industries, which provides pass for its products and services to enter the international market, facilitating the company’s global expansion. Furthermore, high-frequency GMP audits undergone further manifest the stability and reliability of the company’s quality management system. According to the data, as of June 30, 2024, the Group underwent more than 60 GMP audits cumulatively. This included passing the EU QP audit with zero defects on the first attempt, passing the official GMP audit directly on-site in Colombia, and passing the GMP audits in Indonesia, Egypt and other countries. Furthermore, the Group assisted its customers in completing inspections by their overseas partnering MNC pharmaceutical companies and other institution on multiple occasions, and successfully collaborated with its customers in completing the licensing with high recognition. In the fiercely competitive pharmaceutical market, quality is the key to standing out for enterprises. TOT BIOPHARM continuously improves its quality management system, and its achievements fully demonstrate the company's outstanding performance in quality management, which will help the company attract more investment and cooperation opportunities, and thus promote further business development. Overall, TOT BIOPHARM's financial report reveals the company's highlights in multiple aspects. These highlights not only demonstrate the company's current business strength, but also provide solid support for the company's future sustainable development and market competitiveness. Confidence to Rally from 3 Bottoms Ahead of the Industry? The valuation of the pharma industry is often affected by compounding factors in the capital market, and the industry is facing a multitude of challenging trends formed by three bottoms: policy bottom, fundamental bottom, and sentiment bottom. From a policy bottom perspective, the government continues to increase policy support for the pharma industry, providing a stable external environment and development opportunities for the industry. Since the beginning of this year, many regions have issued intensive policies to support pharmaceutical innovation to promote the high-quality development of innovative drugs in an all-round way. And just before this, on July 30th, Shanghai also issued the "Several Opinions on Supporting the Innovative Development of the Whole Chain of the Biomedical Industry", which triggered a heated response in the market. The policy support for innovative drugs will obviously bring new opportunities to the CXO industry, which is known as the "water seller" of innovative drugs. In terms of fundamental bottom, the entire pharma industry has shown weak performance in recent years. Nowadays, with the optimization of industry structure and the improvement of innovation capabilities, the fundamentals of the pharmaceutical sector are gradually improving, and those directions with sustainable profitability are becoming the focus of capital allocation. As regards sentiment bottom, after a long period of sluggish environment, the market is gradually recovering confidence in the pharmaceutical sector, and the recovery of investor sentiment will inject momentum for the valuation repair of the sector. In this context, as an pharmaceutical company, TOT BIOPHARM shows unique advantages in the industry, especially the series of gratifying changes in its fundamentals accompanying the transformation, enabling the company's value growth to be re-examined by the market. Since it shifted to biopharmaceutical CDMO in an all-round manner in 2020, the company has established new growth points from series of actions to layout in the CDMO field. This has withstood continuous verification. Looking ahead, with the increasing demand for global pharma R&D outsourcing services under the industry background, TOT BIOPHARM is expected to further expand its market share in the CDMO business and builds a strong engine for climbing new highs in revenue. Moreover, the company has successfully collaborated with its customers in completing the licensing multiple times, laying a solid foundation for the company's expansion into international markets. Focusing on biopharmaceuticals and emerging from the ADC field, TOT BIOPHARM has established a high-level domestic commercial production line that integrates antibodies, ADC substance, and drug products, and continues to build a cutting-edge ADC CDMO technology platform, representing the company's professional capabilities and technical strength in the field of biopharmaceuticals, especially ADC. Regarding the high technical barriers in the research and production of ADC drugs, TOT BIOPHARM has established a competitive advantage in the field of ADC CDMO with its high standard production line and technology platform, consolidating the company's market position in biopharmaceutical CDMO. Biologics, a well deserved hot field nowadays, contains broad prospects in the ADC market. According to Frost&Sullivan, the global ADC market is expected to grow at a high compound annual growth rate of 30.0% from $7.9 billion in 2022 to $64.7 billion in 2030. The rapid development of the ADC track will also provide broad incremental space for the ADC CDMO business market. TOT BIOPHARM, a pharma company with a deep layout in it, will undoubtedly continue to benefit. In summary, the combination of the three bottoms has brought opportunities for the pharma industry to navigate challenges, while TOT BIOPHARM, with its core competitiveness in the industry and comprehensive advantages in track layout, holds the potential to rally ahead of the entire industry. With the improvement of the market environment and the enhancement of the company's own strength, TOT BIOPHARM is expected to achieve both excellent performance and good valuation. 3. Conclusion Through in-depth analysis of the company and its pharmaceutical sector, TOT BIOPHARM's development potential and future prospects can be clearly seen in the current market environment. The core competitiveness of TOT BIOPHARM, especially its active layout in the biopharmaceutical CDMO business, indicates that the company will occupy a more important position in the future pharmaceutical market. It is believed that TOT BIOPHARM's subsequent market performance will also be worth waiting with the continuous growth of performance and the improvement of market recognition. 26/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

[Press Release] PetroChina (00857.HK / 601857.SS) 2024 Interim Results

EQS Newswire / 26/08/2024 / 19:50 UTC+8 PetroChina Posted Another Record High Operating Results for 1H 2024 (26 August 2024) – PetroChina Company Limited (“PetroChina” or the “Company”, HKSE: 00857, SSE: 601857) announced its operating results for the first half of 2024. The Company strengthened market analysis and proactively responded to multiple challenges. While pursuing high-quality development, it adhered to the principle of seeking progress in a steady manner. Coordinated efforts were made to drive business development and further enhance business quality and profitability, in tandem with the initiative to promote reform, innovation, safety and environmental protection. The core oil and gas businesses and other operations remained stable and profitable, with key production indicators growing steadily. The Company achieved record high first half operating results for three consecutive years. All businesses were profitable, and the financial position remained sound. In accordance with IFRS, the Company posted operating income of RMB 1.6 trillion in the first half of 2024, representing a 5% year-on-year increase. Net profit attributable to equity holders of the Company reached RMB 88.61 billion, up 3.9% year-on-year. The annualized average return on equity amounted to 10.4%. With continuous optimization of its asset-liability structure, the Company retained a robust financial position. The debt-to-asset ratio dropped by 1.4 percentage points to 39.4% from the end of the previous year. It was the lowest first half figure for the last 14 years. Meanwhile, the debt-to-capital ratio declined by 3.9 percentage points to 11.3% from the end of the previous year. It hit the lowest level in the same period for the last 16 years. To reward shareholders, the Board of Directors decided to distribute an interim dividend of RMB 0.22 per share for the first half of 2024, with total dividend payout reaching RMB 40.26 billion. This marks the third consecutive year for the Company to pay a record high interim dividend. Results Review Steady enhancement in oil, gas and new energies supply capacity. As the Company remained committed to effective exploration, significant breakthroughs and discoveries were made in Tarim Basin, Sichuan Basin and Junggar Basin, leading to the discovery of several large-scale proved oil and gas reserves. It made solid progress in scientific and preliminary exploration at ultra-deep (10,000-meter) oil and gas fields. Notably, the drilling of Well-Shenditake 1 exceeded 10,000 meters, setting a new record for the deepest vertical well drilled in Asia. With an emphasis on cost-effective development, the Company strengthened investment and cost management, optimized development strategies, and prioritized capacity building based on profitability metrics. Considerable efforts were devoted to controlling the decline rates of mature oil and gas fields and improving their recovery rates. The Company's overseas asset structure was further optimized, with key projects running smoothly. In the first half of 2024, the Company's total production in oil equivalent terms increased by 1.3% year-on-year to 123 million tons. Crude oil production reached 64.45 million tons, and marketable natural gas output reached 73.18 billion cubic meters. The Company actively promoted the development of large-scale new energies bases and participated in competitive allocation of new energies approval. It newly acquired 7.25 million kilowatts of wind and photovoltaic power generation approval and signed contracts for geothermal heating services covering an area of 46.15 million square meters. In the first half of 2024, the energy output from wind and photovoltaic power plants reached 2.17 billion kilowatt-hours, and power supply for external users reached 950 million kilowatt-hours, 2.5 times and 4.5 times of the same period last year respectively. The Company further advanced the development of CCUS (carbon capture, utilization, and storage) business, and injected 0.84 million tons of CO2. The oil, gas and new energies business generated an operating profit of RMB 91.66 billion, representing a 7.2% year-on-year growth. Substantial progress in transformation and upgrading of refining, chemicals and new materials business. In response to market demands fluctuation, the Company optimized the resources of crude oil, processing load, product mix, and facility maintenance schedules. It strengthened the connection of its industrial chain operations and enhanced the mutual supply of raw materials. While maintaining high utilization rates of ethylene and aromatics facilities, the Company established PetroChina Blue Ocean New Materials Company to actively develop new chemical products and materials. Pursuant to the principles of high-end, intelligent, and green development, the Company continued to drive the transformation and upgrading of refining and chemical operations. Several key ethylene projects progressed in a smooth and orderly manner, including in Jilin Petrochemical, Guangxi Petrochemical and Dushanzi Petrochemical (Tarim Phase II ). In the first half of 2024, the Company processed a total of 0.69 billion barrels of crude oil, up 3.0% year-on-year. The output of refined products reached 60.12 million tons, up 2.1% year-on-year. The output of jet fuel and feature refined products increased by 42.4% and 10% year-on-year respectively. The production of chemical products amounted to 19.04 million tons, representing a 10.2% year-on-year growth. The output of new materials reached 1.07 million tons, representing an increase of 72.0% year-on-year. The refining, chemicals and new materials business achieved an operating profit of RMB 13.63 billion. Continued improvement in marketing capabilities of the marketing business. With in-depth market analysis and forecasting, the Company implemented customized marketing strategies. It enhanced integration of wholesale and retail operations, fuel and non-fuel products, and online and offline channels. Despite a decline in overall market demand, the Company strived to maintain a stable sales of refined products and increase its market share. With an aim to accelerate green and low-carbon transition, the Company actively promoted the development of integrated energy service stations which offer fuel, gas, hydrogen, electricity and non-fuel products. Besides, it further expanded the "Convenience Store + N" operating model to drive high-quality development of non-fuel business. As a result, the non-fuel business saw significant growth in gross profit. The Company optimized its global market layout, striving to reduce oil and gas procurement costs and enrich the variety of traded products. In addition, the export strategies for refined and chemical products were enhanced, leading to an increase in overall value of the industrial chain. In the first half of 2024, the Company's total sales volume of refined products reached 79.05 million tons. Domestic sales volume of these refined products amounted to 58.45 million tons. The marketing business achieved an operating profit of RMB 10.10 billion. Volume and profit growth in natural gas marketing business. The Company capitalized on favorable market condition presented by continuously rising natural gas demand, enhanced the coordination between supply and demand, and continuously optimized the structure of resource pool, which lowered its overall procurement costs. The Company strengthened its market expansion efforts by comprehensively improving natural gas sales channels and customer structure. While vigorously expanding into high-end and premium markets, it intensified efforts to acquire direct-sales and end-user customers. Moreover, the Company relentlessly developed gas power generation and new energies businesses in conjunction with continuous efforts in improving customer services to consolidate and boost its market share. The Company diversified the marketing strategies for spot LNG agent purchases and dedicated deals through exchange platform. The Company also enhanced online trading and redoubled efforts to pass on costs, hence effectively boosting sales volume and profitability. In the first half of 2024, the Company's natural gas sales reached 147.22 billion cubic meters, representing a 12.9% year-on-year increase. The domestic sales volume of natural gas amounted to 114.94 billion cubic meters, up 5.8% from the same period last year. The natural gas marketing business achieved an operating profit of RMB 16.81 billion, representing a 19.0% year-on-year increase. Outlook In the second half of 2024, the global economy is expected to maintain moderate growth and the Chinese economy will remain on an upward trend. The Company will continue to promote high-quality development and adhere to the five major development strategies: innovation, resources, market, internationalization and green and low-carbon development. It will actively respond to market changes, adjust and optimize production and operation strategies on a timely basis, and maintain safe, stable, and profitable operations across oil and gas value chains and of other businesses. The Company will further enhance its development quality and profitability, striving to create greater value for its shareholders. ### Additional information on PetroChina is available at the Company’s website: http://www.petrochina.com.cn Issued by PetroChina Company Limited For further information, please contact:PetroChina Company Limited PR Agency (Overseas media): PRChina LimitedJoanne Liu Fax: (852) 2522 9955Tel: (852) 2522 1838Email: petrochina@prchina.com.hk PR Agency (Domestic media): EverBloom Investment Consulting Co., Ltd.Di Shen Fax: (8610) 8562 3181Tel: (8610) 5166 3828Email: zhongshiyou.list@everbloom.com.cn File: [Press Release] PetroChina 2024 Interim Results 26/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Explore the Wonders of Macao: Participate in the “Experience Macao Limited Edition”

EQS Newswire / 26/08/2024 / 14:00 UTC+8 To showcase Macao’s rich tourism resources and unique culture, the Macao Government Tourism Office (MGTO) officially launched the International “Experience Macao Limited Edition” campaign at an online press conference on August 26 at 11:00 AM (Beijing time). During the conference, MGTO Director Maria Helena de Senna Fernandes, along with representatives from Galaxy Entertainment Group, Melco Resorts & Entertainment, MGM China, Sands China, Wynn Macao, and SJM Holdings, detailed the event’s rules and impressive prizes. This campaign combines an online game with offline experiences, aiming to attract International visitors to explore the enchanting charm of Macao. A major highlight of the campaign is the exclusive theme song “Lovin' My Stay,” created for this campaign by the Macao Government Tourism Office (MGTO). The song is performed by MIYEON of the South Korean girl group (G)I-DLE, who also came to Macao to film the music video (MV). Through this MV, audiences can experience Macao’s unique allure in tune with MIYEON’s music. During the campaign, participants can register on the ExperienceMacaoLimitedEdition.com website and answer three questions related to Macao daily for a chance to win one of 100 “Experience Macao Limited Edition prizes” . The campaign is divided into three phases: Phase 1 from August 26 to September 4, Phase 2 from September 16 to September 25, and Phase 3 from October 7 to October 17. Participants who answer all three questions correctly will have a chance to enter the draw and win opportunities to unlock more experiences in Macao. Prizes include round-trip flights to Macao, premium accommodations, and unique experiences meticulously arranged by MGTO in collaboration with Macao’s six major integrated resorts. These experiences include cultural visits, intangible cultural heritage, Michelin-starred dining, and entertainment activities, providing winners with an unforgettable journey through Macao. Additionally, a special “Ultimate Experience Macao Limited Edition Prize” is set. Among the 100 prize winners, the participant who receives the most likes on social media by sharing their Macao experience before December 31, 2024, will win the Ultimate Experience Macao Limited Edition Prize—a 30-day free trip to Macao. The Ultimate Experience Macao Limited Edition Prize winner will have the opportunity to explore top attractions and rich culture throughout Macao, fully enjoying its endless charm. Whether you are a devoted fan of Macao or a newcomer from around the world, this interactive experience is not to be missed. For more information about the event, please follow the official Instagram account of the Macao Government Tourism Office, @visitmacao, where all winners will be announced. More details can be found on the Macao Government Tourism Office’s other official social media platforms. For more information, please visit: Official Website: ExperienceMacaoLimitedEdition.com Instagram: @visitmacao Facebook: https://www.facebook.com/visitmacao/ 26/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Sinopec Announces FY2024 Interim Results

EQS Newswire / 25/08/2024 / 19:10 UTC+8 Press release (For immediate release) Sinopec Delivered Promising 2024 Interim Results The Board Approved of the “Action of Corporate Value and Return Plan” Proposed to Distribute Cash Dividends of Not Less Than 65% of Annual Profit in Next Three Years (25 August 2024, Beijing, China) China Petroleum & Chemical Corporation ("Sinopec Corp." or the "Company") (HKEX: 386; SSE: 600028) today announced its interim results for the six months ended 30 June 2024. Financial Highlights In accordance with IFRS, the Company’s operating revenue for the first half of 2024 reached RMB 1.58 trillion. Profit attributable to shareholders of the Company was RMB 37.079 billion, up 2.6% year-on-year; basic earnings per share were RMB 0.307, up 2.0% year-on-year. In accordance with CASs, the Company’s net profit attributable to shareholders of the Company was RMB 35.703 billion, up 1.7% year-on-year; basic earnings per share were RMB 0.296, up 1.0% year-on-year. The Board of Directors has resolved to distribute an interim cash dividend of RMB 0.146 per share (tax inclusive). In accordance with CASs, the interim dividend payout ratio amounted to 49.8%. Moreover, the Board of Directors has approved of the share repurchase plan with an aim to boost the enterprise value. The Board of Directors has approved of the “Action of Corporate Value and Return Plan”. In order to share its achievements with shareholders, the Board proposed the profit distribution plan for the next three years (2024-2026). Pursuant to it, the cash dividends payout ratio shall be not less than 65%. The Company’s oil and gas output in the first half reached approximately 258 million barrels of oil equivalent, up 3.1% year-on-year. Natural gas production reached approximately 700.6 billion cubic feet, up 6.0% year-on-year; refinery throughput was 127 million tonnes, up 0.1% year-on-year; total sales volume of refined oil products was approximately 119 million tonnes, up 2.1% year-on-year; ethylene production was 6.496 million tonnes. Focusing on efforts to cut carbon emissions, reduce pollution, increase efficiency and promote green development, the Company formulated the Second Phase Plan of the Green Enterprise Campaign of Sinopec Corp. It set the following main targets through 2028: emission intensities of carbon dioxide and methane decrease by 5% and 20% respectively compared with 2023, capture and utilise 2.5 million tonnes of carbon dioxide per year, 100% compliance rate of carbon emission trading; over 92% comprehensive utilisation rate of industrial solid waste, 100% compliance disposal rate of hazardous waste; comprehensive energy consumption per RMB10,000 of production output decreases by 5% compared with 2023, over 60% reuse rate of wastewater. Mr. Ma Yongsheng, the Chairman of the Company, said: Going forward, we will thoroughly implement reforms to promote high-quality development, attach great importance to innovation-driven growth, accelerate business transformation and upgrading, strengthen lean management, and strive hard to overcome difficulties and create value. The Company will strengthen operational quality and further enhance profitability. By giving full play to our integrated operation, we will optimize the industrial chain and regional layout and reinforce cost management, thereby maximizing our profitability. Enhanced efforts will be made to promote the business transformation and upgrading, and new productive forces will be cultivated and developed. We will commit ourselves to the innovation-driven strategy so as to drive the business transformation and upgrading and the development of emerging businesses. As for the upstream business, we will insist on the expansion of oil and gas business, and the development of natural gas production, supply, storage and marketing system will be accelerated. The development of a multi-energy complementary system comprising “oil and gas + new energies” will be expedited by enhancing efforts to develop new energies such as hydrogen energy, wind power and solar power. As for the refining business, we will speed up the construction of "high-end, intelligent and green" production bases, coordinate the development of low-cost “oil to chemicals” projects and the projects for “oil to specialties with differentiated features”, and proactively formulate the plan for the development of emerging businesses such as new materials and bio-technology. As for the marketing business, we will further optimize the network layout, push for the development of EV battery charging and swapping service and gas filling station network along with the expansion of demonstrating application scenarios for hydrogen mobility. Moreover, the Easy Joy service ecosystem will be enhanced in order to sharpen the competitive edges of our integrated energy service network involving “petrol, gas, hydrogen, power and services”. Meanwhile, the Company will strive to improve ESG and promote sustainable development. Persistent efforts will be made to continually enhance our corporate governance system and establish a modern enterprise system. At the same time, the Company will proactively respond to the climate change, implement Carbon Peak Action Plan and the second phase of Green Enterprise Action Plan in a steady manner. Large-scale application of negative emission technologies such as CCUS will be promoted in conjunction with coordinated efforts to cut carbon emissions, reduce pollution, increase efficiency and promote green development, thereby contributing our efforts to promote the green transition of the society. We will also actively fulfill our social responsibilities and improve stakeholders’ satisfaction. By strengthening the ESG system, we will boost the ESG performance and promote our sustainable development. The Company will vigorously enhance the communication with stakeholders and increase the enterprise value. In adherence to the investor-centric approach, we will continuously improve the quality of our information disclosures and investor relations work. While making persistent efforts to refine the mechanism for stakeholder consultation and feedback, we will reply to investors’ enquiries on a timely basis, increase our recognition in the market and increase the enterprise value. Business Review In the first half of 2024, China’s economy sustained recovery momentum, registering GDP growth of 5.0% year-on-year. Based on the Company’s statistics, domestic demand for natural gas increased rapidly with apparent consumption up by 10% year on year. Due to the decline in diesel demand, domestic consumption of refined oil products decreased by 0.5% year on year. Domestic demand for chemicals kept growing with ethylene equivalent consumption up by 4.3% year on year. In the first half of 2024, international oil prices fluctuated widely, with the average spot price of Platts Brent was USD 84.1 per barrel, up by 5.3% year-on-year. Exploration and Production In the first half of 2024, the Company intensified efforts in high quality exploration and profit-oriented development, yielding good results in adding reserves and production, cutting cost and increasing profit. Domestic production for oil and gas equivalents hit record high for the same period. In terms of exploration, the Company strengthened geophysical, risk and integrated evaluation exploration, and achieved major exploration breakthroughs in shale gas of Sichuan Basin and in the new area of Beibu Gulf Basin. The construction of Shengli Jiyang Shale Oil National Demonstration Zone was promoted efficiently. In terms of crude oil development, the Company carried forward the key capacity building of offshore Shengli, Tahe and Beibu Gulf Basin, and strengthened fine-tuned development in mature fields. In terms of natural gas development, it progressed with the key capacity building projects in Shunbei Zone Two and West Sichuan marine facies gas. It further enhanced the integrated operation of natural gas production, supply, storage and sales and the profitability of the whole natural gas business chain went up remarkably year on year, recording a new high. The Company’s production of oil and gas in the first half of 2024 was 257.66 million barrels of oil equivalent, up by 3.1%, among which domestic crude oil production totaled 126.49 million barrels, up by 1.5% year-on-year and natural gas production reached 700.57 billion cubic feet, up by 6.0% year-on-year. In the first half of 2024, operating revenue of the segment was RMB153.8 billion, representing an increase of 6.1% year-on-year. This was mainly due to the increase in crude oil price and the sales volume of crude oil and natural gas products. In the first half of 2024, the oil and gas lifting cost was RMB753.4 per tonne, representing a decrease of 0.4% year-on-year. In the first half of 2024, this segment seized the opportunity of relative high crude oil prices, spared no efforts to increase reserves, boost production, cut cost, achieved good performance, strengthened the optimization of the whole natural gas industry chain, and realised an operating profit of RMB29.1 billion, representing an increase of RMB3.7 billion or 14.7% year-on-year. Exploration and Production: Summary of Operations Six-month periods ended 30 June Changes 2024 2023 % Oil and gas production (mmboe) 257.66 249.88 3.1 Crude oil production (mmbbls) 140.53 139.68 0.6 China 126.49 124.68 1.5 Overseas 14.04 15.00 (6.4) Natural gas production (bcf) 700.57 660.88 6.0 Refining In the first half of the year, facing severe challenges brought by the weak market demand and narrowing margin of certain refinery products, the Company adhered to the integration of production and marketing by closely following market demand, optimized utilization rate and product mix and increased production based on profitability. It dynamically coordinated procurement, storage and transportation, and production to reduce procurement cost. Besides, it optimised the rhythm of carrying forward the “oil to chemicals” and “oil to specialties” projects, and produced more market-favored products such as gasoline and jet fuel. Efforts were also made to seize opportunities in overseas market and optimized export scheduling and structure. In the first half of 2024, the Company processed 126.69 million tonnes of crude and produced 77.30 million tonnes of refined oil products, up by 1.6% with gasoline and kerosene output up by 6.6% and 15.2% respectively year on year. In the first half of 2024, operating revenues of the segment were RMB749.7 billion, representing an increase of 2.8% year-on-year. This was mainly due to the increased price of refined oil products and others year-on-year resulting from increased price of international crude oil. In the first half of 2024, the unit refining cash operating cost (defined as operating expenses less cost of crude oil and refining feedstock, depreciation and amortisation, taxes other than income tax and other operating expenses, divided by the throughput of crude oil and refining feedstock) was RMB195.4 per tonne, representing a decrease of 4.5% year-on-year, which was mainly due to the decrease in costs of power and fuels resulting from enhancing cost control. In the first half of 2024, the segment focused on optimisation and integration of production and marketing, flexibly and timely adjusted the utilisation rate and product structure following the market demand, made every effort to reduce the impact of rising crude oil procurement costs and weak market demand, and realised an operating profit of RMB7.1 billion, decreased by RMB4.3 billion or 37.6% year-on-year. Refining: Summary of Operations Six-month periods ended 30 June Changes 2024 2023 (%) Refinery throughput (million tonnes) 126.69 126.54 0.1 Gasoline, diesel and kerosene production (million tonnes) 77.30 76.07 1.6 Gasoline (million tonnes) 32.34 30.33 6.6 Diesel (million tonnes) 29.31 32.15 (8.8) Kerosene (million tonnes) 15.65 13.59 15.2 Light chemical feedstock production (million tonnes) 19.79 21.36 (7.4) Note: Includes 100% of the production of domestic joint ventures. Marketing and Distribution In the first half of 2024, the Company actively addressed the challenges of weak diesel demand and rapid growth of electric vehicles. By taking a client-focused approach, it brought its advantages in integrated business into full play and expanded the market through high quality service. The Company carried out special marketing campaign and differentiated marketing strategy, boosting sales of gasoline and jet fuel. Measures were taken to effectively cement existing marketing network and promote the growth of EV battery charging and gas fueling business with charging volume and vehicle LNG operating volume both going up significantly. It promoted steady development of hydrogen transportation and actively transformed into an integrated energy service provider of petro, gas, hydrogen, power and services. At the same time, the Company reinforced the buildup of proprietary brands, enriched diversified non-fuel business models for Easy Joy and upgraded the operating quality of non-fuel business. Total sales volume of refined oil products for the first half of the year was 119.01 million tonnes, up by 2.1%, of which total domestic sales volume accounting for 90.14 million tonnes. In the first half of 2024, the operating revenues of this segment were RMB863.5 billion, decreased by 0.9% year-on-year. This was mainly attributable to decreased demand and sales volume for diesel year-on-year. In the first half of 2024, the segment persisted in integrating and collaborating to achieve profits, spared no effort to expand market and increase sales volume, but was impacted by factors including new energy and LNG substitution. The segment realised an operating profit of RMB14.6 billion, representing a decrease of RMB2.3 billion year-on-year, down by 13.7% year-on-year. The profit of non-fuel business was RMB2.6 billion, representing a decrease of RMB0.09 billion year-on-year. Marketing and Distribution: Summary of Operations Six-month periods ended 30 June Changes 2024 2023 % Total sales volume of refined oil products (million tonnes) 119.01 116.60 2.1 Total domestic sales volume of refined oil products (million tonnes) 90.14 92.47 (2.5) Retail (million tonnes) 56.96 59.76 (4.7) Direct sales and distribution(million tonnes) 33.18 32.71 1.4 Note: The total sales volume of refined oil products includes the amount of refined oil marketing and trading sales volume. As of 30 June 2024 As of 31 Dec 2023 Changes from the end of previous year(%) Total number of Sinopec-branded service stations 30,959 30,958 0.0 Number of convenience stores 28,633 28,431 0.7 Chemicals In the first half of 2024, the domestic chemical market was still in the trough of business cycle. The Company kept up with the market demand and strengthened coordination of refining and chemical business, regional collaboration and integration of production, sales and R&D efforts. It beefed up cost reduction efforts and achieved notable results in tapping potential and raising profits. Feedstock was further diversified to lower cost. The Company also ran profitable units such as aromatics at high utilization rate, arranged utilization rate cut as well as operational shutdown for units with negative marginal profits and increased the proportion of high value-added products steadily. In the first half of the year, ethylene production was 6.496 million tonnes. Production of synthetic fibre monomer and polymer was up by 17.8% year on year. The Company enhanced cooperation with strategic customers, pushed forward tailor-made product services and explored both domestic and overseas markets with export volume up by 17.8%. The total chemical sales volume in the first half reached 40.06 million tonnes with all products produced were sold. In the first half of 2024, the operating revenues of this segment were RMB257.3 billion, up by 5.3% year-on-year. This was mainly due to increase in sales volume and prices of chemical products year-on-year. In the first half of 2024, the segment closely followed the market demand, enhanced integration of production, marketing, research in all aspects, dynamically measured product marginal profit, vigorously optimised the structure of feedstock, facilities and products, made efforts to increase production of high value-added products, enhanced cost control and realised an operating loss of RMB3.2 billion, narrowing by RMB0.2 billion year-on-year. Major Chemical Products: Summary of Operations Unit of production: 1,000 tonnes Six-month periods ended 30 June Changes 2024 2023 (%) Ethylene 6,496 6,875 (5.5) Synthetic resin 9,784 9,793 (0.1) Synthetic fiber monomer and polymer 4,598 3,903 17.8 Synthetic fiber 633 519 22.0 Synthetic rubber 678 670 1.2 Note: Includes 100% of the production of domestic joint ventures. Safety and Health In the first half of 2024, the Company continuously improved the HSE management system and ensured professional HSE operation. It implemented the all-staff safety production responsibility system, launched the “Safety Management Enhancement Year” campaign. The Company strengthened the rectification and elimination of safety risks and potential dangers and maintained the stability of safety production. It promoted the occupational health management system and construction of “A Healthy Company” with health management level going up steadily. Science and Technology Innovation In the first half of 2024, the Company further promoted the reform of the science and technology system and mechanism, sought breakthroughs in key and core technologies, and built national-level R&D institutions for the energy industry, all contributing to better innovation-driven effects. Breakthrough was made in deep and ultra-deep shale gas exploration theory and technology. The shale oil development technology was successfully employed in depression basins such as Jiyang and Northern Jiangsu for building profitable production capacity. The Company achieved industrial application of strip fluidized bed residue hydrogenation catalyst and put into operation the cyclohexene esterification hydrogenation to cyclohexanone unit. It upgraded the intelligent operation center and intelligent production facilities, and put into use digital applications such as digital twins and 5G technologies. Capital Expenditures The Company focused on the quality and return of investment and continued to optimize its capital projects management. In the first half of the year, total capital expenditures were RMB55.893 billion. Capital expenditure for the exploration and production segment was RMB33.788 billion, mainly for crude oil capacity building in Jiyang and Tahe, natural gas capacity building in West Sichuan and the construction of oil and gas storage and transportation facilities. Capital expenditure for the refining segment was RMB9.201 billion, mainly for Zhenhai expansion, technical upgrading in Guangzhou and Maoming companies. Capital expenditure for the marketing and distribution segment was RMB2.952 billion was spent in the marketing and distribution segment, mainly for the development of integrated energy station network, revamping of the existing end-user network and non-fuel business. Capital expenditure for the chemicals segment was RMB8.633 billion, mainly for ethylene projects in Zhenhai phase II and Maoming and high-end materials projects etc. Capital expenditure for the corporate and other segment were RMB1.319 billion, mainly for R&D facilities and information technology application projects. Business Outlook In the second half of 2024, China’s economy is expected to further improve. Domestic demand for natural gas and chemical products is expected to improve, and that for refined oil products will remain stable. Given the impacts of geopolitics, and changes in the global supply, demand and inventory, the international crude oil prices are expected to fluctuate widely. The Company will leverage advantages of integration, and enhance coordinated operation to strive for a high-quality performance. It will stress on the following aspects: E&P: The Company will continue to add oil and gas reserve, stabilize oil output, increase gas production, and cut costs, so as to strive for better profitability. It will enhance exploration and trap pre-exploration, increase the quality and scale of reserves. Besides, it will accelerate the capacity construction of oil and gas production in areas such as Shengli offshore, west Junggar, and Shunbei Zone Two, strengthen the application of technologies for EOR, and take measures to reduce the break-even point. It will expedite the construction of the production, supply, storage, and marketing system of natural gas, diversify the supply of natural gas, reduce resource costs, optimize marketing strategies, and expand high-quality customers. Its plan for the second half of 2024 is to produce 139 million barrels of crude oil and 679.5 billion cubic feet of natural gas. Refining: The Company will adhere will insist on the synergistic development between production and marketing, flexibly adjust the product mix and the utilization rates to ensure efficient operation of the industrial chain to the coordination of production and sales, adjust product slate and utilization rate focusing on profitability, and ensure the efficient operation of the value chain. It will dynamically optimize the procurement scale and rhythm, reduce procurement costs, and improve the slate mix and rhythm of exported products. It will stress insist on low-cost “oil to chemicals” and differentiated “oil to specialty” products”, effectively cut the diesel to gasoline ratio and diesel yield, and push promote the development of special products such as needle coke. In the second half of 2024, the Company plans to process 126 million tonnes of crude oil. Marketing and Distribution: The Company will fully leverage the advantages of integration, strengthen digital and intelligent empowerment, and press hard with market expansion of market and sales. It will keep optimizing the network layout, facilitate the construction of EV battery charging and gas refueling networks and demonstration application of hydrogen-based mobility, improve the comprehensive service of Easy Joy, enhance the quality and profitability of non-fuel businesses, and consolidate and improve the quality of the “petro, gas, hydrogen, power and services” network. In the second half of 2024, it plans to sell 91.09 million tonnes of refined oil products domestically. Chemicals: The Company will actively respond to the bottom of the chemical industry cycle, adhere to the principle of “basic + high-end”, and make every effort to reduce costs, expand markets, and tap potentials for better profits. It will continue to diversify the feed-stock and cut the costs through multiple means. In adherence to the market-oriented approach, it will maintain high utilization of profitable units, and raise the profitability of high-quality assets. It will further strengthen the synergy among production, sales, research and application, intensify promote the development of new materials and high value-added products, and increase profitability. The Company will actively expand domestic and international markets, and strengthen cooperation with strategic customers and tailored services for our products. In the second half of 2024, it plans to produce 6.85 million tonnes of ethylene. Capital Expenditure: The Company plans to spend RMB117.1 billion in the second half of 2024. RMB44.0 billion will be spent in the E&P segment, mainly for the crude oil production capacity building in Jiyang and Tahe, the natural gas production capacity building in west Sichuan, and the storage and transportation facilities building for oil and gas. RMB15.6 billion will be spent in the refining segment, mainly for the expansion of Zhenhai expansion refining and the technical upgrading and technology revamping projects of Guangzhou and Maoming companies. RMB15.4 billion will be spent in the marketing and distribution segment, mainly for developing the network for integrated energy stations, the revamping of the existing network for end-users, and non-fuel businesses. RMB37.2 billion will be spent in the chemical segment, mainly for the construction of ethylene projects in Zhenhai Phase II and Maoming, the aromatics project in Jiujiang and high-end materials projects. RMB4.9 billion will be spent for corporate and others, mainly for R&D and IT development. Appendix: Key financial data and indicators FINANCIAL DATA AND INDICATORS PREPARED IN ACCORDANCE WITH CASs Principal accounting data Items Six-month period ended 30 June Changes over the same period of the preceding year (%) 2024 (RMB million) 2023 (RMB million) (adjusted) Operating income 1,576,131 1,593,682 (1.1) Net profit attributable to equity shareholders of the Company 35,703 35,111 1.7 Net profit attributable to equity shareholders of the Company excluding extraordinary gains and losses 35,582 33,655 5.7 Net cash flow from operating activities 42,269 27,562 53.4 At 30 June 2024 (RMB million) At 31 December 2023 (RMB million) Change from the end of last year (%) Total equity attributable to equity shareholders of the Company 828,140 805,794 2.8 Total assets 2,141,936 2,026,674 5.7 Principal financial indicators Items Six-month period ended 30 June Changes over the same period of the preceding year (%) 2024 (RMB) 2023 (RMB) Basic earnings per share 0.296 0.293 1.0 Diluted earnings per share 0.296 0.293 1.0 Basic earnings per share (excluding extraordinary gains and losses) 0.295 0.281 5.0 Weighted average return on net assets (%) 4.37 4.43 (0.06)percentage points Weighted average return (excluding extraordinary gains and losses) on net assets (%) 4.36 4.25 0.11percentage points FINANCIAL DATA AND INDICATORS PREPARED IN ACCORDANCE WITH IFRS Principal accounting data Items Six-month period ended 30 June Changes over the same period of the preceding year (%) 2024 (RMB million) 2023 (RMB million) Operating profit 51,021 53,696 (5.0) Profit attributable to shareholders of the Company 37,079 36,122 2.6 Net cash generated from operating activities 42,269 27,562 53.4 At 30 June 2024 (RMB million) At 31 December 2023 (RMB million) Change from the end of last year (%) Total equity attributable to shareholders of the Company 825,925 802,989 2.9 Total assets 2,140,524 2,024,696 5.7 Principal financial indicators Items Six-month period ended 30 June Changes over the same period of the preceding year (%) 2024 (RMB) 2023 (RMB) (adjusted) Basic earnings per share 0.307 0.301 2.0 Diluted earnings per share 0.307 0.301 2.0 Return on capital employed (%) 4.30 4.22 0.08 percentage points The following table sets forth the operating revenues, operating expenses and operating profit/(loss) by each segment before elimination of the inter-segment transactions for the periods indicated, and the percentage change between the first half of 2024 and the first half of 2023. Six-month period ended 30 June Changes 2024 2023 (RMB million) (%) Exploration and Production Segment Operating revenues 153,762 144,863 6.1 Operating expenses 124,614 119,455 4.3 Operating profit 29,148 25,408 14.7 Refining Segment Operating revenues 749,665 729,557 2.8 Operating expenses 742,540 718,147 3.4 Operating profit 7,125 11,410 (37.6) Marketing and Distribution Segment Operating revenues 863,497 871,348 (0.9) Operating expenses 848,849 854,379 (0.6) Operating profit 14,648 16,969 (13.7) Chemicals Segment Operating revenues 257,251 244,300 5.3 Operating expenses 260,415 247,658 5.2 Operating loss (3,164) (3,358) (5.8) Corporate and Others Operating revenues 796,568 810,518 (1.7) Operating expenses 792,264 806,961 (1.8) Operating profit 4,304 3,557 21.0 Elimination (1,040) (290) - About Sinopec Corp. Sinopec Corp. is one of the largest integrated energy and chemical companies in China. Its principal operations include the exploration and production, pipeline transportation and sale of petroleum and natural gas; the production, sale, storage and transportation of refinery products, petrochemical products, coal chemical products, synthetic fibre, and other chemical products; the import and export, including an import and export agency business, of petroleum, natural gas, petroleum products, petrochemical and chemical products, and other commodities and technologies; and research, development and application of technologies and information; hydrogen energy business and related services such as hydrogen production, storage, transportation and sales; battery charging and swapping, solar energy, wind energy and other new energy business and related services。 Disclaimer This press release includes "forward-looking statements". All statements, other than statements of historical facts that address activities, events or developments that Sinopec Corp. expects or anticipates will or may occur in the future (including but not limited to projections, targets, reserve volume, other estimates and business plans) are forward-looking statements. Sinopec Corp.'s actual results or developments may differ materially from those indicated by these forward-looking statements as a result of various factors and uncertainties, including but not limited to the price fluctuation, possible changes in actual demand, foreign exchange rate, results of oil exploration, estimates of oil and gas reserves, market shares, competition, environmental risks, possible changes to laws, finance and regulations, conditions of the global economy and financial markets, political risks, possible delay of projects, government approval of projects, cost estimates and other factors beyond Sinopec Corp.'s control. In addition, Sinopec Corp. makes the forward-looking statements referred to herein as of today and undertakes no obligation to update these statements. Investor Inquiries: Media Inquiries: Beijing Hong Kong Tel:(86 10) 5996 0028 Tel:(852) 2522 1838 Fax:(86 10) 5996 0386 Fax:(852) 2521 9955 Email:ir@sinopec.com Email:sinopec@prchina.com.hk File: 【Press Release】Sinopec FY2024 Interim Results 25/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

【Press Release】China XLX Announces 2024 Interim Results

EQS Newswire / 25/08/2024 / 16:29 UTC+8 Press Release (For immediate release) China XLX Announces 2024 Interim Results Quality Improvement, Cost Reduction and Efficiency Enhancement Contributing to Profit Growth 2024 Interim Results Highlights: The Group’s revenue increased by 0.02% YoY to approximately RMB 12.061 billion; Profit attributable to owners of the parent surged by 26% YoY to approximately RMB 687 million; Debt-to-asset ratio has decreased for four consecutive years, and the financial condition has improved year by year. Gearing ratio reducing to 62.7% and finance costs dropping by 18% YoY. (25 August 2024, Hong Kong) China XLX Fertiliser Ltd. (“China XLX” or the “Company”, together with its subsidiaries collectively known as the “Group”) (HKSE: 01866.HK) announced that the Group’s revenue for the six months ended 30 June 2024 (the “Period”) increased by 0.02% YoY to approximately RMB 12.061 billion. Profit attributable to owners of the parent amounted to approximately RMB 687 million, surged by 26% YoY. In the first half of 2024, despite the concentrated release of agricultural demand, demand and supply mismatch in the fertilizer industry still exist. The price of raw materials on the supply side has fluctuated downward, weakening price support for coal chemical products, which has in turn affected the prices of the Group’s fertilizer and fine chemical products. However, with the stable operation of the domestic economy, downstream demand is continuously recovering, leading to significant increases in the Group’s urea, compound fertilizer, and methanol sales. The Group has continued to optimize production processes, strictly control energy consumption indicators, and ensure stable long-term operation. Through quality improvement, cost reduction and efficiency enhancement, the Group has achieved the leading energy efficiency in synthetic ammonia production for thirteen consecutive years. With the decline in raw material costs, the overall gross profit increased by 12% year-on-year (“YoY”), contributing to profit growth for the Group. Revenue derived from the sales of urea increased 9% to approximately RMB3,834 million. This was mainly due to a 25% YoY increase in urea sales volume, but this was partially offset by a 13% YoY decrease in the average selling price. As production capacity released, the output of urea increased by 24% YoY, which helped boost sales volume. Gross profit margin of urea increased by approximately 2 percentage points from approximately 29% in 1H2023 to 31% for 1H2024, benefiting from a 15% decrease in the average sales cost of urea. On one hand, the decline in the price of coal led to a 10% YoY decrease in procurement costs. On the other hand, through the transformation and upgrade of the production lines, production consumption indicator was effectively reduced by 6% YoY. Revenue derived from the sales of compound fertilisers increased by 6% to approximately RMB3,410 million, mainly due to a 13% YoY increase in compound fertilisers sales volume, but partially offset by a 6% YoY decrease in average selling price. The release of new production capacity at the Group’s Northeast base led to a 15% YoY increase in output. At the same time, the continued optimization of the marketing model, and precise marketing strategy for each region and crop, as well as pre-orders through conference marketing, helped boost sales volume. Gross profit margin of compound fertilisers increased by approximately 6 percentage points from approximately 12% in 1H2023 to 18% in 1H2024. With the continuous decline in international potash prices, the Group’s potash procurement price decreased by 18% YoY, resulting in a 12% YoY reduction in average cost of sales. Additionally, as high-efficient compound fertilisers better meet the needs of modern agriculture, with a gross profit margin of 19%, 4 percentage points higher than ordinary fertilisers, the Group increased the proportion of high-efficiency compound fertiliser sales by 23% YoY, effectively improving the gross profit. Revenue derived from the sales of methanol increased 32% to approximately RMB1,291 million. The increase was mainly due to a 1% YoY increase in the average selling price of methanol and a 31% YoY increase in sales volume. In the first half of the year, the domestic economy has steadily advanced with notable progress, and the manufacturing sector has shown significant improvement, which has driven increased demand for methanol in downstream industries. At the same time, our group continued to expand its methanol trading activities and enhanced market competitiveness by providing supporting logistics services. As a result, new trade orders increased by 18% compared to the previous year. The gross profit margin of methanol increased by 10 percentage points from negative 2% in 1H2023 to 8% in 1H2024. Affected by the decline in raw material prices, the average methanol cost of sales decreased by 9% YoY. Revenue derived from the sales of melamine decreased by 4% to approximately RMB397 million. This was mainly due to a 6% YoY decrease in the average selling price of melamine. In the first half of the year, the domestic real estate-related industries experienced a slow recovery, with weak downstream demand. The addition of new production capacity and a rise in operating rates led to an imbalance between supply and demand, causing melamine prices to come under pressure and declined. To mitigate the adverse effects of domestic supply pressures, the group has actively expanded into international markets, securing new overseas orders in countries such as India and Malaysia. This increase in export volume has driven a 3% YoY increase in sales. The gross profit margin of melamine products decreased by 6 percentage points from 36% in 1H2023 to 30% in 1H2024. This was mainly due to the loose supply and demand situation and the weakening of raw material cost support, which resulted in a 6% YoY decrease in the average selling price of melamine. The sales revenue of DMF increased 14% to approximately RMB595 million. This was mainly due to a 31% YoY increase in DMF sales volume, while the average selling price decreased by 13% YoY. Since the planned shutdown and maintenance in the first half of last year, the production equipment has maintained stable operation, effectively increasing production by 30%, driving the increase in sales volume. The gross profit margin of DMF increased by 2 percentage points from 11% in 1H2023 to 13% in 1H2024. The increase was due to innovation of production technology and improvement of equipment, which effectively reduced the consumption of steam and electricity, and lowered the average cost by approximately 15% YoY. The Group has continuously strengthened its production and operations, accelerated capital turnover, reduced working capital occupancy, and enhanced its assets liquidity. At the same time, through various channels and forms of financing, the Group has continued to optimize its debt structure. The debt-toasset ratio has decreased for four consecutive years, and the financial condition has improved year by year. Against the backdrop of a decline in average interest rate, the Group has ensured healthy cash flow while proactively repaying high-interest loans in advance, which effectively reduced the finance costs. During the Period, the Group’s finance costs came down by 18% YoY and the gearing ratio dropped from 64.00% as at the end of 2023 to 62.70% as at the end of June. Looking ahead into the future, Mr. Liu Xingxu, Chairman of China XLX, said, “Against the backdrop of accelerating agricultural productivity improvements, the Group is seizing new trends and opportunities in agricultural services. By utilizing big data and focusing on large-scale farmers, we are restructuring our sales organisation, transforming distributors into service providers. We aim to provide integrated value-added services to end farmers with a focus on “differentiated products + precise services,” enhancing brand influence through team collaboration. At the same time, our group continues to align with long-term strategic goals, focusing on core advantages and deepening core competencies. On one hand, we are further enhancing the technical transformation of existing systems to reduce consumption. On the other hand, we are building new projects with the industry’s most advanced technology to maximize investment returns. To meet the needs of rapid development, we continuously optimize management models and, leveraging group control, establish an adaptable organizational structure to support the realization of development strategies and competitive strategies.” ~ END ~ About China XLX Fertiliser Ltd. China XLX Fertiliser Ltd. is one of the largest and most cost-efficient coal-based urea producers in China. It is principally engaged in developing, manufacturing and selling of urea, compound fertiliser, methanol, dimethyl ether, melamine, furfuryl alcohol, furfural, 2-methylfuran, pharmaceutical intermediates and related differentiated products. The Group adheres to the development strategy of “maintaining overall cost leadership and creating competitive differentiation" while strengthening the core fertiliser operations. With support of the resources in Xinxiang, Xinjiang and Jiangxi, it extends the value chain to upstream new energy and new materials and diversifies into coal chemical related products. The Company’s shares (stock code: 01866.HK) are traded on the main board of the Hong Kong Stock Exchange. Investor and Media Enquiries China XLX Fertiliser Ltd. Gui Lin Tel: 86-135-6942-3415 Email: gui.lin@chinaxlx.com.hk PRChina Limited Rachel Chen Tel: 852-2522 1368 / 852-2522 1838 Email: rchen@prchina.com.hk kliu@prchina.com.hk File: 【Press Release】China XLX Announces 2024 Interim Results 25/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Sun Hung Kai & Co. Announces 2024 Interim Results 

EQS Newswire / 22/08/2024 / 12:00 UTC+8 Conservative positioning continues to drivereturn to profitability Sun Hung Kai & Co. Limited (Stock Code: 86.HK) (“SHK & Co” or the “Company”, together with its subsidiaries, the “Group”) announces a significant turnaround in its interim results for the period ended 30 June 2024, reflecting the benefits of its diversified business model and progress in its strategic transformation amidst volatile and uncertain business environment. Financial Summary Six months ended Year ended (HK$ Million) Jun 2024 Jun 2023 Change Dec 2023 Revenue 1,915.8 1,968.3 -2.7% 3,916.6 Pre-tax profit/(loss) 307.4 36.5 742.2% 76.6 Profit/(loss) attributable to owners of the Company 75.4 (287.5) N/A (471.4) Basic earnings/(losses) per share (HK cents) 3.9 (14.7) N/A (24.1) Interim dividend (HK cents) 12.0 12.0 - 14.0^ Book value per share (HK$) 10.7 11.0 -2.7% 10.8 ^ Second interim dividend Despite challenging market conditions, SHK & Co delivered a revenue of HK$1,915.8 million (1H2023: HK$1,968.3 million), which mainly consisted of interest income of HK$1,650.2 million from the Credit business. Profit attributable to the owners of the Company was HK$75.4 million, a significant turnaround from a loss of HK$287.5 million for the same period last year. The Group remained cautious and focused on managing its investment portfolio proactively and continued to maintain a strong balance sheet with ample liquidity, allowing it to capitalise on opportunities arising from market dislocations. For the six months ended 30 June 2024, the Board has declared an interim dividend of HK12 cents per share, which remains unchanged from the first half of 2023. Business Review Pre-tax contribution for the six months ended Segment assets as at (HK$ Million) Jun 2024 Jun 2023^ Change Jun 2024 Dec 2023^ CREDIT BUSINESS Consumer Finance 400.3 553.8 -27.7% 17,598.0 18,062.9 Mortgage Loans 25.0 71.6 -65.1% 2,311.3 2,674.6 Private Credit -- (10.2) N/A -- -- Sub-total 425.3 615.2 -30.9% 19,909.3 20,737.5 INVESTMENT MANAGEMENT (358.4) (861.4) -58.4% 15,528.3 16,257.4 FUNDS MANAGEMENT 1.3 16.3 -92.0% 21.6 24.9 GMS 239.2 266.4 -10.2% 4,046.5 3,849.7 Total 307.4 36.5 742.2% 39,505.7 40,869.5 ^ Re-presented as term loans of Private Credit were regrouped to Special Situations under Investment Management Credit business maintained its solid performance, contributing a pre-tax profit of HK$425.3 million for the period with lower operating costs than the same period last year, which reflected SHK & Co’s ongoing commitment to operational efficiency. Funds Management business maintained its trend of profitability despite the challenging fundraising environment. Excluding the one-off impact from the sale of revenue share rights in East Point in the first half of 2023, pre-tax contribution from Funds Management grew 116.7% year-on-year, assisting the Group’s transformation into a leading alternative investment platform. It reported robust growth in the collective AUM (Asset under Management) of its funds and that of its fund partners, reaching US$1.2 billion, a new record since the launch of this platform in 2021. The growth in assets under management was driven by a net cash inflow of over US$130 million and market gains of about US$100 million, with good contributions from almost all strategies. The Group is confident in the development of this segment, particularly with a strategic alliance with GAM Investment effective from 1 August 2024. This alliance has expanded its product offerings and enhanced its client coverage and capabilities across Greater China. The multi-family office platform, Family Office Solutions (“FOS”), continued to make strides, expanding client base by leveraging its access to global private investment opportunities. This unit provides customised alternative investment solutions for family offices and high-net-worth individuals with similar investment approaches and horizons, generating returns based on the alignment of interests. Investment Management division also reported significant improvement. The overall return continued to improve over the past two years and recorded a positive gain of 0.4% for the period. Pre-tax loss was narrowed by 58.4% to HK$358.4 million after allocating an internal cost of capital charge of HK$348.7 million, compared to HK$861.4 million for the first half of 2023. This positive development was largely attributed to enhanced performance across Private Equity, Hedge Funds, and Corporate Holdings, while Special Situations and Real Estate continued to deliver solid gains. Alternatives and Real Estate segments recorded an unrealised gain of HK$172.2 million, mainly due to the solid returns contributed by Hedge Funds after actively adjusted towards a more conservative exposure. Mr. Lee Seng Huang, the Group Executive Chairman said, “Throughout the first half of 2024, we have maintained a conservative position, and continued to buyback of our own debt. While the anticipated interest rate cuts offer some hope of relief, 2024 presents a complex landscape. As the global economic recovery remains uncertain with continued geopolitical tensions and uncertainties brought by US presidential election, we remain cautiously optimistic but continue to reduce market exposures. With the new alliance with GAM Investments, we are excited by the potential opportunities it presents and will continue to execute on the buildup of our investment and distribution capabilities.” For more details of the 2024 interim earnings, please refer to the official announcement. - End - About Sun Hung Kai & Co. Sun Hung Kai & Co. Limited (SEHK: 86) (“SHK & Co” / the “Company”, together with its subsidiaries, the “Group”) is a leading Hong Kong-based financial institution recognised for its expertise in alternative investments and wealth management. Since 1969, the Company has built a diversified investment portfolio across public markets, credit and alternatives strategies including real estate and private equity, delivering long-term risk-adjusted returns. Leveraging its deep-rooted Asian heritage, SHK & Co supports and nurtures specialist emerging asset managers in the region, empowering them to excel. SHK & Co also utilises its long-standing investment expertise and resources in providing tailored investment solutions to like-minded partners and ultra-high-net-worth investors through its Family Office Solutions. As of 30 June 2024, the Group held about HK$39.5 billion in total assets. For more information about SHK & Co, please visit www.shkco.com / follow us on LinkedIn. For media enquiries, please contact: Hill and Knowlton Joanne Lam +852 9839 6552 Sidney Leng +852 5443 4320 Lynn Zhang +852 9794 5751 Email: SHKCo@hkstrategies.com 22/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More

Hong Kong Ferry announces FY2024 interim results Revenue increases by 23%

EQS Newswire / 21/08/2024 / 09:15 UTC+8 Highlights of financial results The Group’s revenue for the 6 months ended 30 June 2024 amounted to HK$211 million, up by 23% as compared with the same period last year. Unaudited consolidated net profit after taxation of the Group amounted to HK$87.5 million, which was in line with that for the corresponding period in 2023. Earnings per share amounted to HK$0.25. An interim dividend of HK10 cents per share was declared for FY2024. (21 August 2024, Hong Kong) – Hong Kong Ferry (Holdings) Company Limited (the “Company”, which together with its subsidiaries, is referred to as the “Group”; SEHK stock code: 0050) announced interim results today for the six months ended 30 June 2024. Period Under Review The unaudited consolidated net profit after taxation of the Group for the six months ended 30 June 2024 amounted to HK$87.5 million, which was in line with that for the corresponding period in 2023. Earnings per share was HK$0.25, which was the same as the figure over the corresponding period of last year. Excluding the fair value change of the investment properties, the Group’s underlying profit attributable to shareholders for the period under review was HK$85.5 million, representing an increase of 28% from the same period last year. The Board of Directors has declared an interim dividend of HK10 cents per share (2023: interim dividend of HK10 cents per share) in respect of the year ending 31 December 2024. The interim dividend will be paid on Friday, 27 September 2024 to shareholders whose names appear on the register of members at the close of business on Thursday, 12 September 2024. Property Development and Investment Operations The gross rental income during the period under review arising from the shops and commercial arcadesof the Group amounted to HK$63 million, an increase of 6% as compared with the same period lastyear. At the end of the reporting period, the commercial arcades of Shining Heights, The Spectacle andMetro6 were fully let, and the occupancy rates of Green Code Plaza and Metro Harbour Plaza were72% and 95% respectively. The increase in gross rental income and change of the occupancy rates weremainly attributed to the change in tenant mix. The Royale (8 Castle Peak Road - Castle Peak Bay, Tuen Mun) Joint Venture Development Project During the first half of 2024, two residential units were sold. The remaining residential units and carparking spaces will be offered for sale. The Symphonie (280 Tung Chau Street, Cheung Sha Wan) Redevelopment Project The Group’s redevelopment project ‘‘The Symphonie’’ in Cheung Sha Wan provides a residential grossfloor area of about 100,698 square feet. The certificate of compliance was obtained in November lastyear. The interior fitting-out works are basically completed. Preparations for strata sale or rent willsoon be in place. Due to the strong demand in the rental market in Hong Kong, rental yield rates have increased. Some units may be used for rental purposes to increase the Group’s regular income. Ferry, Shipyard and Related Operations During the period under review, the Ferry, Shipyard and Related Operations recorded a deficit of HK$3 million, a decrease of 23% as compared to the deficit in the same period last year. This was mainly due to the increase in fare for operating the ‘‘North Point - Kwun Tong’’ dangerous goods vehicular ferry service since 28 January 2024 approved by the Transport Department, as well as the sustained recovery of Hong Kong’s tourism industry, which has helped to boost Harbour Cruise - Bauhinia business. Healthcare, Medical Aesthetic and Beauty Services The number of customers of the ‘‘AMOUR’’ medical aesthetic clinic located at Mira Place in Tsim Sha Tsui, with a floor area of about 12,000 square feet, has increased continuously since its opening. For the six months ended 30 June 2024, the turnover had increased by 280% compared with the same period last year. As at 30 June 2024, HK$12 million was recorded as payments received for prepaid packages, which in accordance with standard accounting practices had not been included in the income statement of the period under review. The Group is gradually expanding its medical specialties businesses. In addition to collaborating with ICON, an international cancer care medical group, to set up a cancer centre at H Zentre in Tsim Sha Tsui, the Group has also established in the same building the ‘‘Total HealthCare Specialists Centre’’, which provides specialised services in cardiology, surgery, orthopedics, plastic surgery, rheumatology and urology. The performance has been steadily on the rise and net profits have continued to be recorded during the period under review. During the period under review, the Group launched its pain treatment business and provided services at Mira Place in Tsim Sha Tsui and Metro Harbour Plaza in Tai Kok Tsui respectively. The Group introduced advanced medical equipment in conjunction with professional registered chiropractors and sports therapists, to design personalised treatment plans for pain-suffering patients, which services were well received. Prospects It is expected that the rental income from shops and commercial arcades together with bank interest income will continue to be the major sources of revenue of the Group in the second half of the year. Mr. Gabriel Lee, General Manager of Hong Kong Ferry, said, “Over the past decades, the Group has successfully transformed itself from a ferry and shipyard focused business into an integrated conglomerate. Moving forward, the Group will remain committed to supporting our communities by always “Putting people first” across our diversified development, seizing each opportunity to guard the health and wellbeing, and strive to fulfill its responsibilities and commitments for social development.” For more details, please refer to the 2024 interim results announcement on the Company website at www.hkf.com and the HKEX News website at www.hkexnews.hk. -End- About Hong Kong Ferry (Holdings) Company Limited Established in 1923, Hong Kong Ferry (Holdings) Company Limited in additional to its ferry business, is principally engaged in property development and investment, and to maximize the potential of its land resources, and to share synergies with Henderson Land Group. Since 2022, the Group has expanded and diversified into medical, aesthetic, healthcare services and products, and is committed to providing the most professional, safe and effective services to the public. For further information, please contact: Karen Chui / Josephine Wu Tel: (852) 2159 7719 / 2159 7714 Fax: (852) 3568 8941 Email: ir@hkf.com 21/08/2024 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com
More